CNB Financial (CCNE) 10-Q 7 May 20 2020 Q1 Quarterly report Financial data

Cover

Cover - shares	3 Months Ended
	Mar. 31, 2020	May 05, 2020
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Mar. 31, 2020
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q1
Current Fiscal Year End Date	--12-31
Document Transition Report	false
Entity File Number	000-13396
Entity Registrant Name	CNB FINANCIAL CORP/PA
Entity Central Index Key	0000736772
Entity Incorporation, State or Country Code	PA
Entity Tax Identification Number	25-1450605
Entity Address, Address Line One	1 South Second Street
Entity Address, Address Line Two	P.O. Box 42
Entity Address, City or Town	Clearfield
Entity Address, State or Province	PA
Entity Address, Postal Zip Code	16830
City Area Code	814
Local Phone Number	765-9621
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	false
Entity Shell Company	false
Title of 12(b) Security	Common Stock, no par value
Trading Symbol	CCNE
Security Exchange Name	NASDAQ
Entity Common Stock, Shares Outstanding (in shares)		15,396,617
Amendment Flag	false

Consolidated Balance Sheets

Consolidated Balance Sheets - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
ASSETS
Cash and due from banks	$ 58,922	$ 42,373
Interest bearing deposits with other banks	77,419	150,601
Total cash and cash equivalents	136,341	192,974
Securities available for sale	570,582	542,313
Trading securities	5,507	9,809
Loans held for sale	1,815	930
Loans	2,855,206	2,809,197
Less: unearned discount	(4,546)	(5,162)
Less: allowance for loan losses	(21,915)	(19,473)
Net loans	2,828,745	2,784,562
FHLB, other equity, and restricted equity interests	27,975	27,868
Premises and equipment, net	55,109	54,867
Operating lease assets	18,360	18,422
Bank owned life insurance	67,017	66,538
Mortgage servicing rights	1,578	1,573
Goodwill	38,730	38,730
Core deposit intangible	77	160
Accrued interest receivable and other assets	27,302	24,913
Total Assets	3,779,138	3,763,659
LIABILITIES AND SHAREHOLDERS’ EQUITY
Non-interest bearing deposits	376,840	382,259
Interest bearing deposits	2,723,376	2,720,068
Total deposits	3,100,216	3,102,327
FHLB and other long term borrowings	225,722	227,907
Subordinated debentures	70,620	70,620
Operating lease liabilities	19,397	19,363
Accrued interest payable and other liabilities	38,381	38,476
Total liabilities	3,454,336	3,458,693
Common stock, $0 par value; authorized 50,000,000 shares; issued 15,476,736 shares at March 31, 2020 and 15,360,946 shares at December 31, 2019	0	0
Additional paid in capital	102,128	99,335
Retained earnings	207,698	201,503
Treasury stock, at cost (80,119 and 112,961 shares for March 31, 2020 and December 31, 2019, respectively)	(2,026)	(2,811)
Accumulated other comprehensive income (loss)	17,002	6,939
Total shareholders’ equity	324,802	304,966
Total Liabilities and Shareholders’ Equity	$ 3,779,138	$ 3,763,659

Consolidated Balance Sheets (Pa

Consolidated Balance Sheets (Parenthetical) - $ / shares	Mar. 31, 2020	Dec. 31, 2019
Statement of Financial Position [Abstract]
Common stock, par value (in dollars per share)	$ 0	$ 0
Common stock, shares authorized (in shares)	50,000,000	50,000,000
Common stock, shares issued (in shares)	15,476,736	15,360,946
Treasury stock, shares (in shares)	80,119	112,961

Consolidated Statements of Inco

Consolidated Statements of Income (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
INTEREST AND DIVIDEND INCOME:
Loans including fees	$ 35,510	$ 32,824
Securities:
Taxable	3,880	2,978
Tax-exempt	481	697
Dividends	219	254
Total interest and dividend income	40,090	36,753
INTEREST EXPENSE:
Deposits	7,905	6,587
Borrowed funds	1,227	1,410
Subordinated debentures (includes $21 and $6 accumulated other comprehensive income reclassification for change in fair value of interest rate swap agreements, respectively)	964	998
Total interest expense	10,096	8,995
NET INTEREST INCOME	29,994	27,758
Provision for loan losses	3,079	1,306
NET INTEREST INCOME AFTER PROVISION FOR LOAN LOSSES	26,915	26,452
NON-INTEREST INCOME:
Service charges on deposit accounts	1,527	1,481
Other service charges and fees	590	646
Wealth and asset management fees	1,293	1,042
Net realized gains on available-for-sale securities (includes $0 and $148 accumulated other comprehensive income reclassifications for net realized gains on available-for-sale securities, respectively)	0	148
Net realized and unrealized gains (losses) on trading securities	(588)	800
Net realized and unrealized gains (losses) on trading securities	(588)	800
Mortgage banking	337	239
Bank owned life insurance	479	361
Card processing and interchange income	1,128	1,029
Other	598	407
Total non-interest income	5,364	6,153
NON-INTEREST EXPENSES:
Salaries and benefits	11,397	10,900
Net occupancy expense	3,027	2,866
Amortization of core deposit intangible	83	165
Data processing	1,336	1,185
State and local taxes	581	768
Legal, professional, and examination fees	645	553
Advertising	405	411
FDIC insurance premiums	619	422
Card processing and interchange expenses	796	747
Other	2,853	3,158
Total non-interest expenses	21,742	21,175
INCOME BEFORE INCOME TAXES	10,537	11,430
INCOME TAX EXPENSE (includes ($4) and $30 income tax expense from reclassification items, respectively)	1,724	1,957
NET INCOME	$ 8,813	$ 9,473
EARNINGS PER SHARE:
Basic (in dollars per share)	$ 0.57	$ 0.62
Diluted (in dollars per share)	0.57	0.62
DIVIDENDS PER SHARE:
Cash dividends per share (in dollars per share)	$ 0.17	$ 0.17

Consolidated Statements of In_2

Consolidated Statements of Income (unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Income Statement [Abstract]
Accumulated other comprehensive income reclassification for change in fair value of interest rate swap agreements	$ 21
Accumulated other comprehensive income reclassification for change in fair value of interest rate swap agreements, before 2017-12 adoption		$ 6
Accumulated other comprehensive income reclassifications for net realized gains on available-for-sale securities	0	148
Income tax expense from reclassification	$ (4)	$ 30

Consolidated Statements of Comp

Consolidated Statements of Comprehensive Income (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
NET INCOME	$ 8,813	$ 9,473
Net change in fair value of interest rate swap agreements designated as cash flow hedges:
Unrealized gain (loss) on interest rate swaps, net of tax of $14 and $87 respectively	(346)
Unrealized gain (loss) on interest rate swaps, net of tax of $0 and ($4), respectively before 2017-12 adoption		(100)
Reclassification adjustment for losses recognized in earnings, net of tax of ($2) and ($7) respectively	17
Reclassification adjustment for losses recognized in earnings, net of tax of $(9) and $(31), respectively before 2017-12 adoption		5
Net change in fair value of interest rate swap agreements designated as cash flow hedges	(329)
Net change in fair value of interest rate swap agreements designated as cash flow hedges before 2017-12 adoption		(95)
Net change in unrealized gains on securities available for sale:
Unrealized holding gains (losses) arising during the period, net of tax of ($2,763) and ($1,348), respectively	10,392	5,068
Reclassification adjustment for realized gains included in net income, net of tax of $0 and $31, respectively	0	(117)
Unrealized gain on other securities available-for-sale	10,392	4,951
Other comprehensive income	10,063	4,856
COMPREHENSIVE INCOME	$ 18,876	$ 14,329

Consolidated Statements of Co_2

Consolidated Statements of Comprehensive Income (unaudited) (Parenthetical) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Statement of Comprehensive Income [Abstract]
Unrealized gain (loss) on interest rate swaps, tax	$ 92
Unrealized gain (loss) on interest rate swaps, tax before 2017-12 adoption		$ 26
Reclassification adjustment for losses recognized in earnings, tax	(4)	(1)
Unrealized (losses) gains on other securities available for sale arising during the period, tax	(2,762)	(1,348)
Reclassification adjustment for realized gains included in net income, tax	$ 0	$ 31

Consolidated Statements of Cash

Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:
Net income	$ 8,813	$ 9,473
Adjustments to reconcile net income to net cash provided by operations:
Provision for loan losses	3,079	1,306
Depreciation and amortization of premises and equipment, operating leases assets, core deposit intangible, and mortgage servicing rights	1,299	1,509
Amortization and accretion of securities premiums and discounts, deferred loan fees and costs, net yield and credit mark on acquired loans, and unearned income	(812)	(409)
Net realized gains on sales of available-for-sale securities	0	(148)
Net realized and unrealized (gains) losses on trading securities	588	(800)
Proceeds from sale of trading securities	5,860	236
Purchase of trading securities	2,000	(144)
Gain on sale of loans	(243)	(84)
Net gains on dispositions of premises and equipment and foreclosed assets	(15)	0
Proceeds from sale of loans	8,536	4,569
Origination of loans held for sale	(9,412)	(7,118)
Income on bank owned life insurance	(479)	(361)
Stock-based compensation expense	549	592
Changes in:
Accrued interest receivable and other assets	(4,061)	(707)
Accrued interest payable, lease liabilities, and other liabilities	(1,285)	(6,520)
NET CASH PROVIDED BY OPERATING ACTIVITIES	14,417	1,394
CASH FLOWS FROM INVESTING ACTIVITIES:
Proceeds from maturities, prepayments and calls of available-for-sale securities	27,389	20,152
Proceeds from sales of available-for-sale securities	0	11,403
Purchase of available-for-sale securities	(46,882)	(9,252)
Loan origination and payments, net	(46,383)	(51,635)
Redemption (purchase) of FHLB, other equity, and restricted equity interests	(107)	1,379
Purchase of premises and equipment	(1,327)	(2,399)
Proceeds from the sale of premises and equipment and foreclosed assets	145	8
NET CASH USED BY INVESTING ACTIVITIES	(67,165)	(30,344)
Net change in:
Checking, money market and savings accounts	888	88,105
Certificates of deposit	(2,999)	(41,532)
Purchase of treasury stock	(324)	(201)
Cash dividends paid	(2,618)	(2,591)
Proceeds from stock offering, net of issuance costs	3,353	0
Repayment of long-term borrowings	(2,185)	(5,112)
NET CASH PROVIDED BY FINANCING ACTIVITIES	(3,885)	38,669
NET INCREASE (DECREASE) IN CASH AND CASH EQUIVALENTS	(56,633)	9,719
CASH AND CASH EQUIVALENTS, Beginning	192,974	45,563
CASH AND CASH EQUIVALENTS, Ending	136,341	55,282
Cash paid during the period for:
Interest	9,933	8,942
Income taxes	78	1,250
SUPPLEMENTAL NONCASH DISCLOSURES:
Transfers to other real estate owned	165	66
Grant of restricted stock awards from treasury stock	892	1,055
Grant of performance based restricted stock awards from treasury stock	217	0
Right of use assets obtained in exchange for lease liabilities	$ 0	$ 16,478

Consolidated Statements of Chan

Consolidated Statements of Changes in Shareholders' Equity (unaudited) - USD ($) $ in Thousands	Total	Additional Paid-In Capital	Retained Earnings	Treasury Stock	Accumulated Other Comprehensive Income (Loss)	Restricted Stock	Restricted StockTreasury Stock	Performance Shares	Performance SharesTreasury Stock
Beginning balance at Dec. 31, 2018	$ 262,830	$ 97,602	$ 171,780	$ (2,556)	$ (3,996)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	9,473		9,473
Other comprehensive income (loss)	4,856				4,856
Restricted stock award grants	0	(1,055)		1,055
Performance based restricted stock award grants (8,351 shares)	592	592
Purchase of treasury stock	(201)			(201)
Cash dividends declared	(2,591)		(2,591)
Ending balance at Mar. 31, 2019	274,959	97,139	178,662	(1,702)	860
Beginning balance at Dec. 31, 2019	304,966	99,335	201,503	(2,811)	6,939
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	8,813		8,813
Other comprehensive income (loss)	10,063				10,063
Performance based restricted stock award grants	0	(217)		217
Restricted stock award grants	0	(892)		892
Performance based restricted stock award grants (8,351 shares)	549	549
Issuance of common stock, net of issuance costs (115,790 shares)	3,353	3,353
Purchase of treasury stock						$ (211)	$ (211)	$ (113)	$ (113)
Cash dividends declared	(2,618)		(2,618)
Ending balance at Mar. 31, 2020	$ 324,802	$ 102,128	$ 207,698	$ (2,026)	$ 17,002

Consolidated Statements of Ch_2

Consolidated Statements of Changes in Shareholders' Equity (unaudited) (Parenthetical) - $ / shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Forfeiture of restricted stock award grants (in shares)	0
Restricted stock award grants (in shares)	35,160	39,790
Issuance of common stock, net of issuance costs (in shares)	115,790
Performance-based restricted stock award (in shares)	8,351
Cash dividends declared (in dollars per share)	$ 0.17	$ 0.17
Purchase of treasury stock (in shares)		0
Restricted Stock
Purchase of treasury stock (in shares)	7,211	7,700
Performance Shares
Purchase of treasury stock (in shares)	3,458

Basis of Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2020
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Basis of Presentation	BASIS OF PRESENTATION The accompanying consolidated financial statements have been prepared pursuant to rules and regulations of the SEC and in compliance with accounting principles generally accepted in the United States of America (“GAAP”). Because this report is based on an interim period, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted. In the opinion of management of the registrant, the accompanying consolidated financial statements as of March 31, 2020 and for the three month period ended March 31, 2020 and 2019 include all adjustments, consisting of only normal recurring adjustments, necessary for a fair presentation of the financial condition and the results of operations for the periods presented. The financial performance reported for CNB Financial Corporation (the “Corporation”) for the three month period ended March 31, 2020 is not necessarily indicative of the results to be expected for the full year. This information should be read in conjunction with the Corporation’s Annual Report on Form 10-K for the period ended December 31, 2019 (the “ 2019 Form 10-K”). All dollar amounts are stated in thousands, except share and per share data and other amounts as indicated. Certain amounts appearing in the consolidated financial statements and notes thereto for prior periods have been reclassified to conform with the current presentation. The reclassifications had no effect on net income or stockholders’ equity as previously reported. Risks and Uncertainties The outbreak of the novel strain of coronavirus, or COVID-19, has adversely impacted a broad range of industries in which the Corporation's clients operate and could impair their ability to fulfill their financial obligations to the Corporation. On March 11, 2020, the World Health Organization declared COVID-19 a global pandemic, indicating that almost all public commerce and related business activities must be, to varying degrees, curtailed, with the goal of decreasing the rate of new infections. The spread of the COVID-19 outbreak has caused significant disruptions in the U.S. economy and has disrupted banking and other financial activity in the areas in which the Corporation operates. While there has been no material impact to the Corporation’s employees to date, the COVID-19 pandemic could also potentially create widespread business continuity issues for the Corporation. The federal government has taken several actions designed to mitigate the economic impact. Most notably, the Coronavirus Aid, Relief and Economic Security (“CARES”) Act, which was signed into law at the end of March 2020, allocates $2 trillion for COVID-19 related relief and initiatives. Among other things, the CARES Act provides direct financial aid to American families and economic stimulus to significantly impacted industry sectors. The CARES Act also includes extensive emergency funding for hospitals and providers. In addition to the general impact of the COVID-19 pandemic, certain provisions of the CARES Act as well as other recent legislative and regulatory relief efforts are expected to have a material impact on the Corporation's operations. The Corporation's business is dependent upon the willingness and ability of its employees and customers to conduct banking and other financial transactions. If the global response to contain the COVID-19 pandemic requires further restricted measures or is unsuccessful, the Corporation could experience a material adverse effect on its business, financial condition, results of operations and cash flows. Since the extent to which the COVID-19 pandemic impacts our operations will depend on future developments that are highly uncertain, the Corporation cannot estimate the impact on its business, financial condition or near or long-term financial or operational results with reasonable certainty. Accordingly, the Corporation is disclosing potentially material items of which it is aware. Asset valuation : Currently, the Corporation does not expect the COVID-19 pandemic to affect its ability to account timely for the assets on its balance sheet; however, this could change in future periods due to any number of potential impacts from the COVID-19 pandemic. The COVID-19 pandemic could cause a further and sustained decline in the Corporation's stock price or the occurrence of what management would deem to be a triggering event that could, under certain circumstances, cause us to perform a goodwill impairment test, resulting in an impairment charge being recorded for that period. In the event that the Corporation concludes that all or a portion of its goodwill is impaired, a non-cash charge for the amount of such impairment would be recorded to earnings. Such a charge would have no impact on tangible capital or regulatory capital. Lending operations and accommodations to borrowers : In keeping with regulatory guidance to continue to assist borrowers during the COVID-19 pandemic, and as detailed in the CARES Act, the Corporation has implemented a payment deferral program for its commercial lending clients that are adversely affected by the pandemic. Depending on the demonstrated need of the client, the Corporation is deferring either the full loan payment or the principal component of the loan payment for up to six months . As of March 31, 2020, the deferred loan payment commitments were 561 loans, totaling $264 million , comprised of (i) 150 loans, totaling $151 million , for which principal and interest were deferred, and (ii) 411 loans, totaling $113 million , for which principal only was deferred. In accordance with interagency guidance issued in March 2020, these short term deferrals are not considered troubled debt restructurings. The Corporation is participating in the Paycheck Protection Program (“PPP”) established by the CARES Act for loans provided under the auspices of the Small Business Administration (“SBA”). Under this program, the Corporation expects to lend money primarily to its existing loan and/or deposit customers, based on a pre-determined SBA-developed formula, intended to incentivize small business owners to retain their employees. The PPP was designed such that a loan originated under this program will be forgiven if the small business retains its employees and level of payroll through the first two months of the loan. These loans carry a customer rate of 1.00% plus a processing fee that varies depending on the balance of the loan at origination and have a two-year maturity. As of April 16, 2020, the Corporation has committed approximately $177 million , or 1,031 PPP loan relationships, under this program, at a rate of 1.00% coupled with processing fees estimated at approximately $6 million . As of April 16, 2020, the SBA funds allocated in the original PPP authorization were fully utilized. Additional funding was made available on April 24, 2020 under the Paycheck Protection Program and Health Care Enhancement Act ("PPP Enhancement Act"). The PPP Enhancement Act authorizes additional funding under the CARES Act of $310 billion for PPP loans to be issued by financial institutions through the SBA. The Corporation is participating in the PPP Enhancement Act. It is the Corporation's understanding that loans funded through the PPP program are fully guaranteed by the U.S. government. Should those circumstances change, the Corporation could be required to establish additional allowance for loan loss through additional provision for loan loss expense charged to earnings. Credit : The Corporation is working with customers directly affected by the COVID-19 pandemic. The Corporation is prepared to offer short-term assistance in accordance with regulator guidelines. As a result of the current economic slowdown related to the COVID-19 pandemic, the Corporation is engaging in more frequent communication with borrowers to better understand their situation and the challenges faced, allowing it to respond proactively as needs and issues arise. Should economic conditions worsen, the Corporation could experience further increases in its required allowance for loan losses and record additional provision expense. It is possible that the Corporation's asset quality measures could worsen at future measurement periods if the effects of the COVID-19 pandemic are prolonged.

Recent Accounting Pronouncement

Recent Accounting Pronouncements	3 Months Ended
	Mar. 31, 2020
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	RECENT ACCOUNTING PRONOUNCEMENTS In June 2016, the FASB issued an Accounting Standards Update ("ASU") 2016-13, "Financial Instruments – Credit Losses" which will require recognition of an entity’s current estimate of all expected credit losses for assets measured at amortized cost. The amendment requires the measurement of all expected credit losses for financial assets held at the reporting date, based on historical credit loss experience, current market conditions, and reasonable and supportable forecast. This eliminates the probable initial recognition threshold in current GAAP. The update will be effective for interim and annual reporting periods beginning after December 15, 2019, with early adoption permitted for interim and annual reporting periods beginning after December 15, 2018. In November 2018, the FASB issued ASU 2018-19, "Codification Improvements to Topic 326, Financial Instruments – Credit Losses." The amendment clarifies that receivables arising from operating leases are not within the scope of Subtopic 326-20 and should be accounted for in accordance with Topic 842, "Leases." In April 2019, ASU 2019-04, “Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments,” was issued to address certain codification improvements and to provide certain accounting policy electives related to accrued interest as well as disclosure related to credit losses, among other things. In May 2019, ASU 2019-05, “Financial Instruments—Credit Losses (Topic 326): Targeted Transition Relief,” was issued to provide transition relief in connection with the adoption of ASU 2016-03 whereby entities would have the option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. The CARES Act provides financial institutions with the option to delay the adoption of ASU No. 2016-13, “Financial Instruments – Credit Losses,” until the earlier of December 31, 2020 or until the national emergency related to the COVID-19 pandemic is terminated. Given the complexity of the processes necessary to properly evaluate, document and implement the current expected credit losses methodology, combined with the extraneous circumstances impacted on its employees, caused by the spread of the coronavirus, the Corporation opted to delay the adoption of ASU No. 2016-13 and recorded its provision for loan losses under the incurred loss model that existed prior to ASU 2016-13. Prior to passage of the CARES Act, based upon the Corporation's fourth quarter parallel run, assessment of the composition, characteristics and credit quality of the Corporation's loan and investment securities portfolio, as well as the economic conditions in effect as of the adoption date, management estimates the adoption of ASU 2016-13 will result in an increase of approximately 20-30% to the Corporation's allowance for credit losses, as reported in its Annual Report Form 10-K for the fiscal year ended December 31, 2019. The adjustment to record the allowance for credit losses may fall outside of management’s estimated increase based on completion of the Corporation's evaluation of qualitative factors and forecasts adjustments to estimate expected credit losses inherent in the loan portfolio. In January 2017, the FASB issued ASU 2017-04, “Intangibles - Goodwill and Other (Topic 350) - Simplifying the Test for Goodwill Impairment” (“ASU 2017-04”). ASU 2017-04 simplifies the accounting for goodwill impairment for all entities by requiring impairment charges to be based on the first step in the previous two-step impairment test. Under the new guidance, if a reporting unit’s carrying amount exceeds its fair value, an entity will record an impairment charge based on that difference. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard eliminates the prior requirement to calculate a goodwill impairment charge using Step 2, which requires an entity to calculate any impairment charge by comparing the implied fair value of goodwill with its carrying amount. ASU 2017-04 was effective for the Corporation on January 1, 2020 and did not have a material impact on the Corporation's financial statements. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 modifies disclosure requirements on fair value measurements based on the concepts in the Concepts Statement, including the consideration of costs and benefits. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. ASU 2018-13 was effective for the Corporation on January 1, 2020 and did not have a material impact on the Corporation's financial statement disclosures. In August 2018, the FASB issued ASU 2018-14, "Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans." ASU 2018-14 amends ASC 715-20, "Compensation - Retirement Benefits - Defined Benefit Plans - General." The amended guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other post-retirement plans by removing and adding certain disclosures for these plans. The eliminated disclosures include (a) the amounts in accumulated Other Comprehensive Income ("OCI") expected to be recognized in net periodic benefit costs over the next fiscal year, and (b) the effects of a one percentage point change in assumed health care cost trend rates on the net periodic benefit costs and the benefit obligation for post-retirement health care benefits. Additional disclosures include descriptions of significant gains and losses affecting the benefit obligation for the period. ASU 2018-14 was effective for the Corporation on January 1, 2020 and did not have a material impact on the Corporation's financial statement disclosures. In August 2018, the FASB issued ASU 2018-15, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) - Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract” (“ASU 2018-15”). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by these amendments. ASU 2018-15 was effective for the Corporation on January 1, 2020 and did not have a material impact on the Corporation's financial statements. In March 2020, the FASB issued ASU No. 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." The amendments in this update provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. It provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this update are effective for all entities as of March 12, 2020 through December 31, 2022. The Corporation is currently evaluating the impact of the reference rate reform on the Corporation's consolidated financial statements. In March 2020, various regulatory agencies, including the Board of Governors of the Federal Reserve System (the "Federal Reserve") and the Federal Deposit Insurance Corporation (the "FDIC”) issued an interagency statement on loan modifications and reporting for financial institutions working with customers affected by the COVID-19 pandemic. The interagency statement was effective immediately and impacted accounting for loan modifications. Under Accounting Standards Codification 310-40, “Receivables - Troubled Debt Restructurings by Creditors” (“ASC 310-40”), a restructuring of debt constitutes a troubled debt restructuring (“TDR”) if the creditor, for economic or legal reasons related to the debtor’s financial difficulties, grants a concession to the debtor that it would not otherwise consider. The agencies confirmed with the staff of the FASB that short-term modifications made on a good faith basis in response to the COVID-19 pandemic to borrowers who were current prior to any relief, are not to be considered TDRs. This includes short-term (e.g., six months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. Borrowers considered current are those that are less than 30 days past due on their contractual payments at the time a modification program is implemented. See Note 1 of the footnotes to the consolidated financial statements for disclosure of the impact to date.

Securities

Securities	3 Months Ended
	Mar. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Securities	SECURITIES Securities available for sale at March 31, 2020 and December 31, 2019 are as follows: March 31, 2020 December 31, 2019 Amortized Unrealized Fair Amortized Unrealized Fair Cost Gains Losses Value Cost Gains Losses Value U.S. Gov’t sponsored entities $ 119,158 $ 6,908 $ 0 $ 126,066 $ 124,189 $ 2,924 $ (19 ) $ 127,094 State & political subdivisions 99,926 3,664 (298 ) 103,292 101,177 3,288 (102 ) 104,363 Residential & multi-family mortgage 295,695 12,052 (227 ) 307,520 273,404 4,117 (885 ) 276,636 Corporate notes & bonds 8,350 12 (740 ) 7,622 8,350 14 (282 ) 8,082 Pooled SBA 24,168 933 0 25,101 25,063 274 (163 ) 25,174 Other 1,020 0 (39 ) 981 1,020 0 (56 ) 964 Total $ 548,317 $ 23,569 $ (1,304 ) $ 570,582 $ 533,203 $ 10,617 $ (1,507 ) $ 542,313 At March 31, 2020 and December 31, 2019 , there were no holdings of securities of any one issuer, other than the U.S. Government sponsored entities, in an amount greater than 10% of shareholders’ equity. The Corporation’s residential and multi-family mortgage securities are issued by government sponsored entities. Trading securities at March 31, 2020 and December 31, 2019 are as follows: March 31, 2020 December 31, 2019 Corporate equity securities $ 3,699 $ 7,946 Mutual funds 487 807 Certificates of deposit 614 350 Corporate notes and bonds 655 655 U.S. Government sponsored entities 52 51 Total $ 5,507 $ 9,809 Securities with unrealized losses at March 31, 2020 and December 31, 2019 , aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, are as follows: March 31, 2020 Less than 12 Months 12 Months or More Total Description of Securities Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. Gov’t sponsored entities $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 State & political subdivisions 3,761 (111 ) 682 (187 ) 4,443 (298 ) Residential & multi-family mortgage 2,382 (63 ) 2,822 (164 ) 5,204 (227 ) Corporate notes & bonds 0 0 4,848 (740 ) 4,848 (740 ) Pooled SBA 0 0 0 0 0 0 Other 0 0 981 (39 ) 981 (39 ) $ 6,143 $ (174 ) $ 9,333 $ (1,130 ) $ 15,476 $ (1,304 ) December 31, 2019 Less than 12 Months 12 Months or More Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. Gov’t sponsored entities $ 7,040 $ (3 ) $ 14,989 $ (16 ) $ 22,029 $ (19 ) State & political subdivisions 826 (5 ) 684 (97 ) 1,510 (102 ) Residential & multi-family mortgage 41,841 (346 ) 32,555 (539 ) 74,396 (885 ) Corporate notes & bonds 0 0 4,718 (282 ) 4,718 (282 ) Pooled SBA 8,560 (80 ) 6,075 (83 ) 14,635 (163 ) Other 0 0 964 (56 ) 964 (56 ) $ 58,267 $ (434 ) $ 59,985 $ (1,073 ) $ 118,252 $ (1,507 ) The Corporation evaluates securities for other-than-temporary impairment on a quarterly basis, or more frequently when economic or market conditions warrant such an evaluation. At March 31, 2020 and December 31, 2019 , management performed an assessment for possible other-than-temporary impairment of the Corporation’s debt securities, relying on information obtained from various sources, including publicly available financial data, ratings by external agencies, brokers and other sources. Based on the results of the assessment, management believes impairment of these debt securities at March 31, 2020 and December 31, 2019 to be temporary. For the securities that comprise corporate notes and bonds and the securities that are issued by state and political subdivisions, management monitors publicly available financial information, such as filings with the Securities and Exchange Commission, in order to evaluate the securities for other-than-temporary impairment. For financial institution issuers, management monitors information from quarterly “call” report filings that are used to generate Uniform Bank Performance Reports. All other securities that were in an unrealized loss position at the balance sheet date were reviewed by management, and issuer-specific documents were reviewed as appropriate given the following considerations; the financial condition and near-term prospects of the issuer and whether downgrades by bond rating agencies have occurred, the length of time and extent to which fair value has been less than cost, and whether management does not have the intent to sell these securities and it is likely that it will not be required to sell the securities before their anticipated recovery. As of March 31, 2020 and December 31, 2019 , management concluded that the securities described in the previous paragraph were not other-than-temporarily impaired for the following reasons: • There is no indication of any significant deterioration of the creditworthiness of the institutions that issued the securities. • All contractual interest payments on the securities have been received as scheduled, and no information has come to management’s attention through the processes previously described which would lead to a conclusion that future contractual payments will not be timely received. The Corporation does not intend to sell and it is not more likely than not that it will be required to sell the securities in an unrealized loss position before recovery of its amortized cost basis. On March 31, 2020 and December 31, 2019 , securities carried at $409,616 and $405,200 , respectively, were pledged to secure public deposits and for other purposes as provided by law. The following is a schedule of the contractual maturity of securities available for sale at March 31, 2020 : Amortized Cost Fair Value 1 year or less $ 64,728 $ 64,979 1 year – 5 years 90,138 93,743 5 years – 10 years 65,049 70,592 After 10 years 7,519 7,666 227,434 236,980 Residential & multi-family mortgage 295,695 307,520 Pooled SBA 24,168 25,101 Other 1,020 981 Total debt securities $ 548,317 $ 570,582 Mortgage and asset backed securities and pooled SBA securities are not due at a single date; periodic payments are received based on the payment patterns of the underlying collateral. Information pertaining to security sales on available for sale securities is as follows: Proceeds Gross Gains Gross Losses Three months ended March 31, 2020 $ 0 $ 0 $ 0 Three months ended March 31, 2019 $ 11,403 $ 152 $ 4 The tax provision related to these net realized gains was $0 and $31 during the three months ended March 31, 2020 and 2019, respectively. Subsequent to March 31, 2020, the Corporation received $50,902 in proceeds from security sales on available for sale securities and recognized a net realized gain of $2,033 , comprised of $2,100 in gross gains and $67 in gross losses. The Corporation’s decision to sell these securities was based on a proactive approach to reduce higher concentration levels in bond types and geographies. Given the total fair value of the securities available for sale portfolio of $570,582 , at March 31, 2020, the Corporation believes this transaction does not represent a significant impact on the overall portfolio.

Business Combinations

Business Combinations	3 Months Ended
	Mar. 31, 2020
Business Combinations [Abstract]
Business Combinations	BUSINESS COMBINATIONS On December 18, 2019, CNB Financial Corporation (“CNB"), CNB Bank (“CNB Bank") and Bank of Akron (“Akron") entered into an Agreement and Plan of Merger (the “Agreement"), pursuant to which CNB will acquire Akron. Under the terms of the Agreement, Akron will be merged with and into CNB Bank (the “Merger") with CNB Bank continuing as the surviving entity. At December 31, 2019, Akron had $388.5 million in assets, $341.4 million in deposits and $38.7 million in shareholders' equity. Following the completion of the Merger, Akron will operate as part of CNB’s BankOnBuffalo division. The Agreement provides that shareholders of Akron will have the right to elect to receive, for each share of Akron common stock, either (x) $215.00 in cash or (y) 6.6729 shares of CNB common stock. Elections will be subject to proration procedures whereby at least 75% of Akron shares will be exchanged for CNB common stock. The shareholders of Akron voted to approve the Agreement and Plan of Merger on March 18, 2020. CNB and Akron expect to consummate the transaction in the third quarter of 2020 following the receipt of the requisite regulatory approvals and the satisfaction of all closing conditions.

Loans

Loans	3 Months Ended
	Mar. 31, 2020
Receivables [Abstract]
Loans	LOANS Total net loans at March 31, 2020 and December 31, 2019 are summarized as follows: March 31, 2020 December 31, 2019 Commercial, industrial and agricultural $ 1,090,915 $ 1,046,665 Commercial mortgages 846,215 814,002 Residential real estate 814,657 814,030 Consumer 94,425 124,785 Credit cards 8,683 7,569 Overdrafts 311 2,146 Less: unearned discount (4,546 ) (5,162 ) allowance for loan losses (21,915 ) (19,473 ) Loans, net $ 2,828,745 $ 2,784,562 At March 31, 2020 and December 31, 2019 , net unamortized loan fees of $3,267 and $3,092 , respectively, have been included in the carrying value of loans. The Corporation’s outstanding loans and related unfunded commitments are primarily concentrated within central and northwest Pennsylvania, central and northeast Ohio and western New York. The Bank attempts to limit concentrations within specific industries by utilizing dollar limitations to single industries or customers, and by entering into participation agreements with third parties. Collateral requirements are established based on management’s assessment of the customer. The Corporation maintains lending policies to control the quality of the loan portfolio. These policies delegate the authority to extend loans under specific guidelines and underwriting standards. These policies are prepared by the Corporation’s management and reviewed and ratified annually by the Corporation’s Board of Directors. Pursuant to the Corporation’s lending policies, management considers a variety of factors when determining whether to extend credit to a customer, including loan-to-value ratios, FICO scores, quality of the borrower’s financial statements, and the ability to obtain personal guarantees. Commercial, industrial and agricultural loans comprised 38% and 37% of the Corporation’s total loan portfolio at March 31, 2020 and December 31, 2019 , respectively. Commercial mortgage loans comprised 30% and 29% of the Corporation’s total loan portfolio at March 31, 2020 and December 31, 2019 , respectively. Management assigns a risk rating to all commercial loans at loan origination. The loan-to-value policy guidelines for commercial, industrial and agricultural loans are generally a maximum of 80% of the value of business equipment, a maximum of 70% of the value of accounts receivable, and a maximum of 60% of the value of business inventory at loan origination. The loan-to-value policy guideline for commercial mortgage loans is generally a maximum of 85% of the appraised value of the real estate. Residential real estate loans comprised 29% and 29% of the Corporation’s total loan portfolio at March 31, 2020 and December 31, 2019 , respectively. The loan-to-value policy guidelines for residential real estate loans vary depending on the collateral position and the specific type of loan. Higher loan-to-value terms may be approved with the appropriate private mortgage insurance coverage. The Corporation also originates and prices loans for sale into the secondary market. Loans so originated are classified as loans held for sale and are excluded from residential real estate loans reported above. The rationale for these sales is to mitigate interest rate risk associated with holding lower rate, long-term residential mortgages in the loan portfolio and to generate fee revenue from sales and servicing the loan. The Corporation also offers a variety of unsecured and secured consumer loan and credit card products which represented less than 4% of the total loan portfolio at both March 31, 2020 and December 31, 2019 . Terms and collateral requirements vary depending on the size and nature of the loan. Transactions in the allowance for loan losses for the three months ended March 31, 2020 were as follows: Commercial,Industrial Commercial Mortgages Residential Real Estate Consumer Credit Cards Overdrafts Total Allowance for loan losses, January 1, 2020 $ 8,287 $ 6,952 $ 1,499 $ 2,411 $ 84 $ 240 $ 19,473 Charge-offs (25 ) 0 (143 ) (592 ) (31 ) (119 ) (910 ) Recoveries 18 172 3 43 1 36 273 Provision (benefit) for loan losses 2,252 368 99 276 58 26 3,079 Allowance for loan losses, March 31, 2020 $ 10,532 $ 7,492 $ 1,458 $ 2,138 $ 112 $ 183 $ 21,915 Transactions in the allowance for loan losses for the three months ended March 31, 2019 were as follows: Commercial, Industrial and Agricultural Commercial Mortgages Residential Real Estate Consumer Credit Cards Overdrafts Total Allowance for loan losses, January 1, 2019 $ 7,341 $ 7,490 $ 2,156 $ 2,377 $ 103 $ 237 $ 19,704 Charge-offs 0 (17 ) (98 ) (549 ) (26 ) (128 ) (818 ) Recoveries 4 0 65 46 5 34 154 Provision (benefit) for loan losses 442 1,373 (740 ) 166 23 42 1,306 Allowance for loan losses, March 31, 2019 $ 7,787 $ 8,846 $ 1,383 $ 2,040 $ 105 $ 185 $ 20,346 The following table presents the balance in the allowance for loan losses and the recorded investment in loans by portfolio segment and is based on the Corporation’s impairment method as of March 31, 2020 and December 31, 2019 . The recorded investment in loans excludes accrued interest and unearned discounts due to their insignificance. March 31, 2020 Commercial, Industrial and Agricultural Commercial Mortgages Residential Real Estate Consumer Credit Cards Overdrafts Total Allowance for loan losses: Ending allowance balance attributable to loans: Individually evaluated for impairment $ 3,489 $ 1,264 $ 51 $ 0 $ 0 $ 0 $ 4,804 Collectively evaluated for impairment 7,009 5,912 1,407 2,138 112 183 16,761 Acquired with deteriorated credit quality 0 0 0 0 0 0 0 Modified in a troubled debt restructuring 34 316 0 0 0 0 350 Total ending allowance balance $ 10,532 $ 7,492 $ 1,458 $ 2,138 $ 112 $ 183 $ 21,915 Loans: Individually evaluated for impairment $ 8,663 $ 12,172 $ 460 $ 0 $ 0 $ 0 $ 21,295 Collectively evaluated for impairment 1,079,220 826,966 814,197 94,425 8,683 311 2,823,802 Acquired with deteriorated credit quality 0 512 0 0 0 0 512 Modified in a troubled debt restructuring 3,032 6,565 0 0 0 0 9,597 Total ending loans balance $ 1,090,915 $ 846,215 $ 814,657 $ 94,425 $ 8,683 $ 311 $ 2,855,206 December 31, 2019 Commercial, Industrial and Agricultural Commercial Mortgages Residential Real Estate Consumer Credit Cards Overdrafts Total Allowance for loan losses: Ending allowance balance attributable to loans: Individually evaluated for impairment $ 645 $ 1,264 $ 34 $ 0 $ 0 $ 0 $ 1,943 Collectively evaluated for impairment 7,614 5,358 1,465 2,411 84 240 17,172 Acquired with deteriorated credit quality 0 0 0 0 0 0 0 Modified in a troubled debt restructuring 28 330 0 0 0 0 358 Total ending allowance balance $ 8,287 $ 6,952 $ 1,499 $ 2,411 $ 84 $ 240 $ 19,473 Loans: Individually evaluated for impairment $ 8,078 $ 2,410 $ 465 $ 0 $ 0 $ 0 $ 10,953 Collectively evaluated for impairment 1,035,494 804,360 813,565 124,785 7,569 2,146 2,787,919 Acquired with deteriorated credit quality 0 523 0 0 0 0 523 Modified in a troubled debt restructuring 3,093 6,709 0 0 0 0 9,802 Total ending loans balance $ 1,046,665 $ 814,002 $ 814,030 $ 124,785 $ 7,569 $ 2,146 $ 2,809,197 The following tables present information related to loans individually evaluated for impairment, including loans modified in troubled debt restructurings, by portfolio segment as of March 31, 2020 and December 31, 2019 and for the three months ended March 31, 2020 and 2019 : March 31, 2020 Unpaid Principal Balance Recorded Investment Allowance for Loan Losses Allocated With an allowance recorded: Commercial, industrial and agricultural $ 7,111 $ 7,068 $ 3,523 Commercial mortgage 6,542 4,312 1,580 Residential real estate 480 460 51 With no related allowance recorded: Commercial, industrial and agricultural 4,780 4,627 0 Commercial mortgage 14,666 14,425 0 Residential real estate 0 0 0 Total $ 33,579 $ 30,892 $ 5,154 December 31, 2019 Unpaid Principal Balance Recorded Investment Allowance for Loan Losses Allocated With an allowance recorded: Commercial, industrial and agricultural $ 2,657 $ 1,476 $ 673 Commercial mortgage 6,541 4,349 1,594 Residential real estate 485 465 34 With no related allowance recorded: Commercial, industrial and agricultural 9,845 9,695 0 Commercial mortgage 4,903 4,770 0 Residential real estate 0 0 0 Total $ 24,431 $ 20,755 $ 2,301 The unpaid principal balance of impaired loans includes the Corporation’s recorded investment in the loan and amounts that have been charged off. Three months ended March 31, 2020 Three months ended March 31, 2019 Average Interest Cash Basis Average Interest Cash Basis With an allowance recorded: Commercial, industrial and agricultural $ 4,272 $ 17 $ 17 $ 2,158 $ 38 $ 38 Commercial mortgage 4,331 37 37 7,267 40 40 Residential real estate 463 5 5 0 0 0 With no related allowance recorded: Commercial, industrial and agricultural 7,161 42 42 3,376 54 54 Commercial mortgage 9,598 158 158 4,065 18 18 Residential real estate 0 0 0 500 7 7 Total $ 25,825 $ 259 $ 259 $ 17,366 $ 157 $ 157 The following table presents the recorded investment in nonaccrual loans and loans past due over 90 days still on accrual by class of loans as of March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 Nonaccrual Past Due Over 90 Days Still on Accrual Nonaccrual Past Due Over 90 Days Still on Accrual Commercial, industrial and agricultural $ 12,144 $ 16 $ 11,644 $ 0 Commercial mortgages 14,237 0 4,533 0 Residential real estate 4,663 0 4,724 59 Consumer 810 0 835 0 Credit cards 0 17 0 2 Total $ 31,854 $ 33 $ 21,736 $ 61 Nonaccrual loans and loans past due over 90 days still on accrual include both smaller balance homogeneous loans that are collectively evaluated for impairment and individually classified impaired loans. The following table presents the aging of the recorded investment in past due loans as of March 31, 2020 and December 31, 2019 by class of loans. March 31, 2020 30-59 Days Past Due 60-89 Days Past Due Greater Than 89 Days Past Due Total Past Due Loans Not Past Due Total Commercial, industrial and agricultural $ 2,604 $ 6,251 $ 4,809 $ 13,664 $ 1,077,251 $ 1,090,915 Commercial mortgages 11,773 179 2,599 14,551 831,664 846,215 Residential real estate 3,285 623 2,601 6,509 808,148 814,657 Consumer 450 238 433 1,121 93,304 94,425 Credit cards 33 33 17 83 8,600 8,683 Overdrafts 0 0 0 0 311 311 Total $ 18,145 $ 7,324 $ 10,459 $ 35,928 $ 2,819,278 $ 2,855,206 December 31, 2019 30-59 Days Past Due 60-89 Days Past Due Greater Than 89 Days Past Due Total Past Due Loans Not Past Due Total Commercial, industrial and agricultural $ 1,273 $ 548 $ 3,784 $ 5,605 $ 1,041,060 $ 1,046,665 Commercial mortgages 162 183 2,594 2,939 811,063 814,002 Residential real estate 3,383 1,270 2,714 7,367 806,663 814,030 Consumer 412 311 415 1,138 123,647 124,785 Credit cards 48 54 2 104 7,465 7,569 Overdrafts 0 0 0 0 2,146 2,146 Total $ 5,278 $ 2,366 $ 9,509 $ 17,153 $ 2,792,044 $ 2,809,197 Troubled Debt Restructurings The terms of certain loans have been modified as troubled debt restructurings. The modification of the terms of such loans included either or both of the following: a reduction of the stated interest rate of the loan or an extension of the maturity date at a stated rate of interest lower than the current market rate for new debt with similar risk. The following table presents the number of loans, loan balances, and specific reserves for loans that have been restructured in a troubled debt restructuring as of March 31, 2020 and December 31, 2019 . March 31, 2020 December 31, 2019 Number of Loans Loan Balance Specific Reserve Number of Loans Loan Balance Specific Reserve Commercial, industrial and agricultural 10 $ 3,032 $ 34 10 $ 3,093 $ 28 Commercial mortgages 13 6,565 316 13 6,709 330 Residential real estate 0 0 0 0 0 0 Consumer 0 0 0 0 0 0 Credit cards 0 0 0 0 0 0 Total 23 $ 9,597 $ 350 23 $ 9,802 $ 358 There were no loans modified as troubled debt restructurings during the three months ended March 31, 2020 or 2019, respectively. A loan is considered to be in payment default once it is 90 days contractually past due under the modified terms. There were no loans modified as troubled debt restructurings for which there was a payment default within a twelve-month cycle following the modification during the period ended March 31, 2020 and March 31, 2019 . There were no principal balances forgiven in connection with the loan restructurings. In order to determine whether a borrower is experiencing financial difficulty, the Corporation evaluates the probability that the borrower will default on any of its debt payments in the foreseeable future without a loan modification. This evaluation is performed using the Corporation’s internal underwriting policies. The Corporation has no further loan commitments to customers whose loans are classified as a troubled debt restructuring. Generally, nonperforming troubled debt restructurings are restored to accrual status when the obligation is brought current, has performed in accordance with the contractual terms for a reasonable period of time (generally six months) and the ultimate collectability of the total contractual principal and interest is no longer in doubt. Credit Quality Indicators The Corporation classifies commercial, industrial and agricultural loans and commercial mortgage loans into risk categories based on relevant information about the ability of borrowers to service their debt, such as current financial information, historical payment experience, credit documentation, public information, and current economic trends, among other factors. The Corporation uses the following definitions for risk ratings: Special Mention: Loans classified as special mention have a potential weakness that deserves management’s close attention. If left uncorrected, these potential weaknesses may result in deterioration of the repayment prospects for the loan or of the Corporation’s credit position at some future date. Substandard: Loans classified as substandard are inadequately protected by the current net worth and paying capacity of the obligor or of the collateral pledged, if any. Loans so classified have a well-defined weakness or weaknesses that jeopardize the liquidation of the debt. They are characterized by the distinct possibility that the Corporation will sustain some loss if the deficiencies are not corrected. Doubtful: Loans classified as doubtful have all the weaknesses inherent in those classified as substandard, with the added characteristic that the weaknesses make collection or liquidation in full, on the basis of currently existing facts, conditions, and values, highly questionable and improbable. Loans not rated as special mention, substandard, or doubtful are considered to be pass rated loans. All loans included in the following tables have been assigned a risk rating within 12 months of the balance sheet date. March 31, 2020 Pass Special Mention Substandard Doubtful Total Commercial, industrial and agricultural $ 1,049,414 $ 13,444 $ 28,057 $ 0 $ 1,090,915 Commercial mortgages 799,848 22,388 23,979 0 846,215 Total $ 1,849,262 $ 35,832 $ 52,036 $ 0 $ 1,937,130 December 31, 2019 Pass Special Mention Substandard Doubtful Total Commercial, industrial and agricultural $ 1,004,445 $ 16,696 $ 25,524 $ 0 $ 1,046,665 Commercial mortgages 780,798 18,837 14,367 0 814,002 Total $ 1,785,243 $ 35,533 $ 39,891 $ 0 $ 1,860,667 The Corporation considers the performance of the loan portfolio and its impact on the allowance for loan losses. For residential real estate, consumer, and credit card loan classes, the Corporation also evaluates credit quality based on the aging status of the loan, which was previously presented, and by payment activity. The following table presents the recorded investment in residential, consumer, and credit card loans based on payment activity as of March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 Residential Real Estate Consumer Credit Cards Residential Real Estate Consumer Credit Cards Performing $ 809,994 $ 93,615 $ 8,666 $ 809,247 $ 123,950 $ 7,567 Nonperforming 4,663 810 17 4,783 835 2 Total $ 814,657 $ 94,425 $ 8,683 $ 814,030 $ 124,785 $ 7,569 The Corporation’s portfolio of residential real estate and consumer loans maintained within Holiday Financial Services Corporation (“Holiday”) are considered to be subprime loans. Holiday is a subsidiary that offers small balance unsecured and secured loans, primarily collateralized by automobiles and equipment, to borrowers with higher risk characteristics than are typical in the Bank’s consumer loan portfolio. Holiday’s loan portfolio is summarized as follows at March 31, 2020 and December 31, 2019 : 3/31/2020 12/31/2019 Consumer $ 25,855 $ 28,122 Less: unearned discount (4,546 ) (5,162 ) Total $ 21,309 $ 22,960

Leases

Leases	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Leases	LEASES Operating lease assets represent our right to use an underlying asset during the lease term and operating lease liabilities represent our obligation to make lease payments arising from the lease. Operating lease assets and liabilities are recognized at lease commencement based on the present value of the remaining lease payments using a discount rate that represents our incremental borrowing rate at the lease commencement date. Operating lease cost, which is comprised of amortization of the operating lease asset and the implicit interest accreted on the operating lease liability, is recognized on a straight-line basis over the lease term, and is recorded in net occupancy expense in the consolidated statements of income. The Corporation leases certain full-serve branch offices, land and equipment. Leases with an initial term of twelve months or less are not recorded on the balance sheet. Most leases include one or more options to renew and the exercise of the lease renewal options are at the Corporation's sole discretion. The Corporation includes lease extension and termination options in the lease term if, after considering relevant economic factors, it is is reasonably certain the Corporation will exercise the option. Certain lease agreements of the Corporation include rental payments adjusted periodically for changes in the consumer price index. Leases Classification March 31, 2020 December 31, 2019 Assets: Operating lease assets Operating lease assets $ 18,360 $ 18,422 Finance lease assets Premises and equipment, net (1) 483 501 Total leased assets $ 18,843 $ 18,923 Liabilities: Operating lease liabilities Operating lease liabilities $ 19,397 $ 19,363 Finance lease liabilities Accrued interest payable and other liabilities 609 629 Total leased liabilities $ 20,006 $ 19,992 (1) Finance lease assets are recorded net of accumulated amortization of $733 as of March 31, 2020 and $715 as of December 31, 2019. The components of the Corporation's net lease expense for the three months ended March 31, 2020 and 2019, respectively, were as follows: Three months ended March 31, Lease Cost Classification 2020 2019 Operating lease cost Net occupancy expense $ 455 $ 405 Variable lease cost Net occupancy expense 24 34 Finance lease cost: Amortization of leased assets Net occupancy expense 18 18 Interest on lease liabilities Interest expense - borrowed funds 7 8 Sublease income (1) Net occupancy expense (21 ) (21 ) Net lease cost $ 483 $ 444 (1) Sublease income excludes rental income from owned properties. The following table sets forth future minimum rental payments under noncancelable leases with terms in excess of one year as of March 31, 2020 : Maturity of Lease Liabilities as of March 31, 2020 Operating Leases (1) Finance Leases Total 2020 $ 1,209 $ 79 $ 1,288 2021 1,636 105 1,741 2022 1,682 105 1,787 2023 1,572 105 1,677 2024 1,538 105 1,643 After 2024 19,373 210 19,583 Total lease payments 27,010 709 27,719 Less: Interest 7,613 100 7,713 Present value of lease liabilities $ 19,397 $ 609 $ 20,006 Other information related to the Corporation's lease liabilities as of the three months ended March 31, 2020 and 2019, respectively, were as follows: Lease Term and Discount Rate March 31, 2020 March 31, 2019 Weighted-average remaining lease term (years) Operating leases 18.4 17.3 Finance leases 6.8 7.8 Weighted-average discount rate Operating leases 3.52 % 3.66 % Finance leases 4.49 % 4.54 % Other Information March 31, 2020 March 31, 2019 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 212 $ 192

Deposits

Deposits	3 Months Ended
	Mar. 31, 2020
Banking and Thrift [Abstract]
Deposits	DEPOSITS Total deposits at March 31, 2020 and December 31, 2019 are summarized as follows: 3/31/2020 12/31/2019 Percentage Checking, non-interest bearing $ 376,840 $ 382,259 (1.4 )% Checking, interest bearing 617,864 628,579 (1.7 )% Savings accounts 1,680,695 1,663,673 1.0 % Certificates of deposit 424,817 427,816 (0.7 )% Total $ 3,100,216 $ 3,102,327 (0.1 )%

Stock Compensation

Stock Compensation	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Stock Compensation	STOCK COMPENSATION The Corporation has a stock incentive plan, which is administered by a committee of the Board of Directors and which permits the Corporation to provide various types of stock-based compensation to its key employees, directors, and/or consultants, including time-based and performance-based shares of restricted stock. The Corporation previously maintained the CNB Financial Corporation 2009 Stock Incentive Plan, which terminated in accordance with its terms on February 10, 2019, and currently maintains the CNB Financial Corporation 2019 Omnibus Incentive Plan (the "2019 Stock Incentive Plan"), which was approved by the Corporation’s shareholders and became effective on April 16, 2019. For key employees, the vesting of time-based restricted stock is one-third, one-fourth, or one-fifth of the granted restricted shares per year, beginning one year after the grant date, with 100% vesting on the third, fourth or fifth anniversary of the grant date, respectively. Prior to 2018, for non-employee directors, the vesting schedule was one-third of the granted restricted shares per year, beginning one year after the grant date, with 100% vested on the third anniversary of the grant date. Beginning in 2018, stock compensation received by non-employee directors vests immediately. At March 31, 2020 , there was no unrecognized compensation cost related to stock-based compensation awarded under this plan and, except for the time-based and performance-based restricted stock awards disclosed below and in previous filings, no other stock-based compensation was granted during the three month period ended March 31, 2020 and 2019 . In addition to the time-based restricted stock disclosed above, the Corporation’s Board of Directors grants performance-based restricted stock awards (“PBRSAs”) to key employees. The number of PBRSAs will depend on certain performance conditions earned over a three year period and are also subject to service-based vesting. In 2020, awards with a maximum of 18,100 shares in aggregate were granted to key employees. In 2019, awards with a maximum of 16,681 shares in aggregate were granted to key employees. In 2018, awards with a maximum of 15,657 shares in aggregate were granted to key employees. Compensation expense for the restricted stock awards is recognized over the requisite service period noted above based on the fair value of the shares at the date of grant. Nonvested restricted stock awards are recorded as a reduction of additional paid-in-capital in shareholders’ equity until earned. Compensation expense resulting from time-based, performance-based and director restricted stock awards was $549 and $592 for the three months ended March 31, 2020 and 2019, respectively. There was $1,562 and $1,026 of total unrecognized compensation cost related to unvested restricted stock awards, as of March 31, 2020 and December 31, 2019 , respectively. The total income tax benefit related to the recognized compensation cost of vested restricted stock awards was $115 and $124 for the three months ended March 31, 2020 and 2019, respectively. A summary of changes in time-based nonvested restricted stock awards for the three months ended March 31, 2020 follows: Shares Per Share Weighted Average Grant Date Fair Value Nonvested at beginning of period 58,370 $ 24.96 Granted 23,658 29.56 Vested (26,262 ) 24.08 Nonvested at end of period 55,766 $ 27.42 The above table excludes 11,502 shares in restricted stock awards that were granted at a weighted average fair value of $29.56 and immediately vested. Compensation expense resulting from the immediately vested shares was $340 for the three months ended March 31, 2020 and is included in the previously disclosed $549 above. The fair value of shares vested was $1,101 and $1,227 during the three months ended March 31, 2020 and 2019, respectively.

Earnings Per Share

Earnings Per Share	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Earnings Per Share	EARNINGS PER SHARE Basic earnings per share is computed by dividing net income, excluding net earnings allocated to participating securities, by the weighted average number of shares outstanding during the applicable period, excluding outstanding participating securities. Diluted earnings per share is computed using the weighted average number of shares determined for the basic computation plus the dilutive effect of potential common shares issuable under certain stock compensation plans. For the three months ended March 31, 2020 and 2019 , there were no outstanding stock options to include in the diluted earnings per share calculations and the impact of performance-based shares was immaterial. Unvested share-based payment awards that contain nonforfeitable rights to dividends or dividend equivalents (whether paid or unpaid) are participating securities and are included in the computation of earnings per share pursuant to the two-class method. The Corporation has determined that its outstanding unvested stock awards are participating securities. The computation of basic and diluted earnings per share is shown below: Three months ended March 31, 2020 2019 Basic earnings per common share computation: Net income per consolidated statements of income $ 8,813 $ 9,473 Net earnings allocated to participating securities (30 ) (39 ) Net earnings allocated to common stock $ 8,783 $ 9,434 Distributed earnings allocated to common stock $ 2,608 $ 2,579 Undistributed earnings allocated to common stock 6,175 6,855 Net earnings allocated to common stock $ 8,783 $ 9,434 Weighted average common shares outstanding, including shares considered participating securities 15,333 15,229 Less: Average participating securities (52 ) (62 ) Weighted average shares 15,281 15,167 Basic earnings per common share $ 0.57 $ 0.62 Diluted earnings per common share computation: Net earnings allocated to common stock $ 8,783 $ 9,434 Weighted average common shares outstanding for basic earnings per common share 15,281 15,167 Add: Dilutive effects of assumed exercises of stock options 0 0 Weighted average shares and dilutive potential common shares 15,281 15,167 Diluted earnings per common share $ 0.57 $ 0.62

Derivative Instruments

Derivative Instruments	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Derivative Instruments	DERIVATIVE INSTRUMENTS On September 7, 2018, the Corporation executed an interest rate swap agreement with a 5 -year term and an effective date of September 15, 2018 in order to hedge cash flows associated with $10 million of a subordinated note that was issued by the Corporation during 2007 and elected cash flow hedge accounting for the agreement. The Corporation’s objective in using this derivative is to add stability to interest expense and to manage its exposure to interest rate risk. The interest rate swap involves the receipt of variable-rate amounts in exchange for fixed-rate payments from September 15, 2018 to September 15, 2023 without the exchange of the underlying notional amount. At March 31, 2020 , the variable rate on the subordinated debt was 2.29% (LIBOR plus 155 basis points) and the Corporation was paying 4.53% ( 2.98% fixed rate plus 155 basis points). As of March 31, 2020 and December 31, 2019 , no derivatives were designated as fair value hedges or hedges of net investments in foreign operations. Additionally, the Corporation does not use derivatives for trading or speculative purposes and currently does not have any derivatives that are not designated as hedges. The following tables provide information about the amounts and locations of activity related to the interest rate swaps designated as cash flow hedges within the Corporation’s consolidated balance sheet and statement of income as of March 31, 2020 and December 31, 2019 and for the three months ended March 31, 2020 and 2019 : Fair value as of Balance Sheet Location March 31, 2020 December 31, 2019 Interest rate contracts Accrued interest and other liabilities $ (901 ) $ (485 ) For the Three Months (a) (b) (c) (d) (e) Interest rate contracts $ (329 ) Interest expense – $ (21 ) Other $ 0 For the Three Months (a) (b) (c) (d) (e) Interest rate contracts $ (95 ) Interest expense – $ (6 ) Other $ 0 (a) Amount of Gain or (Loss) Recognized in Other Comprehensive Loss on Derivative (Effective Portion), net of tax (b) Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income (Effective Portion) (c) Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income (Effective Portion) (d) Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded from Effectiveness Testing) (e) Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded from Effectiveness Testing) Amounts reported in accumulated other comprehensive income (loss) related to the interest rate swap will be reclassified to interest expense as interest payments are made on the subordinated debentures. Such amounts reclassified from accumulated other comprehensive income (loss) to interest expense in the next twelve months are expected to be $229 . As of March 31, 2020 and December 31, 2019 , a cash collateral balance in the amount of $1,050 and $750 , respectively, was maintained with a counterparty to the interest rate swaps. These balances are included in interest bearing deposits with other banks on the consolidated balance sheets. The Corporation entered into certain interest rate swap contracts that are not designated as hedging instruments. These derivative contracts relate to transactions in which the Corporation enters into an interest rate swap with a customer while at the same time entering into an offsetting interest rate swap with another financial institution. In connection with each swap transaction, the Corporation agrees to pay interest to the customer on a notional amount at a variable interest rate and receive interest from the customer on a similar notional amount at a fixed interest rate. Concurrently, the Corporation agrees to pay another financial institution the same fixed interest rate on the same notional amount and receive the same variable interest rate on the same notional amount. The transaction allows the Corporation’s customers to effectively convert a variable rate loan to a fixed rate. Because the Corporation acts as an intermediary for its customer, changes in the fair value of the underlying derivative contracts offset each other and do not impact the Corporation’s results of operations. The Corporation pledged cash collateral to another financial institution with a balance $4,400 as of March 31, 2020 and $2,000 as of December 31, 2019 . This balance is included in interest bearing deposits with other banks on the consolidated balance sheets. The Corporation may require its customers to post cash or securities as collateral on its program of back-to-back swaps depending upon the specific facts and circumstances surrounding each loan and individual swap. In addition, certain language is included in the International Swaps and Derivatives Association agreement and loan documents where, in default situations, the Corporation is permitted to access collateral supporting the loan relationship to recover any losses suffered on the derivative asset or liability. The Corporation may be required to post additional collateral to swap counterparties in the future in proportion to potential increases in unrealized loss positions. The following table provides information about the amounts and locations of activity related to the back-to-back interest rate swaps within the Corporation’s consolidated balance sheet as of March 31, 2020 and December 31, 2019 : Notional Amount Weighted Average Maturity (in years) Weighted Average Fixed Rate Weighted Average Variable Rate Fair Value March 31, 2020 3rd Party interest rate swaps $ 35,061 7.5 4.13 % 1 month LIBOR + 2.27% $ 4,461 (a) Customer interest rate swaps (35,061 ) 7.5 4.13 % 1 month LIBOR + 2.27% (4,461 ) (b) December 31, 2019 3rd Party interest rate swaps $ 35,382 7.7 4.13 % 1 month LIBOR + 2.27 $ 1,877 (a) Customer interest rate swaps (35,382 ) 7.7 4.13 % 1 month LIBOR + 2.27 (1,877 ) (b) (a) Reported in accrued interest receivable and other assets within the consolidated balance sheets (b) Reported in accrued interest payable and other liabilities within the consolidated balance sheets

Fair Value

Fair Value	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Fair Value	FAIR VALUE Fair Value Measurement Fair value is defined as the exchange price that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. A fair value hierarchy has also been established which requires an entity to maximize the use of observable inputs and minimize the use of unobservable inputs when measuring fair value. The following three levels of inputs are used to measure fair value: Level 1: Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date. Level 2: Significant other observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data. Level 3: Significant unobservable inputs that reflect a company’s own assumptions about the assumptions that market participants would use in pricing an asset or liability. The fair values of most trading securities and securities available for sale are determined by obtaining quoted prices on nationally recognized securities exchanges (Level 1 inputs) or matrix pricing, which is a mathematical technique widely used in the industry to value debt securities without relying exclusively on quoted prices for the specific securities but rather relying on the securities’ relationship to other benchmark quoted securities (Level 2 inputs). These models utilize the market approach with standard inputs that include, but are not limited to benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, bids, offers and reference data. For certain securities that observable inputs about the specific issuer are not available, fair values are estimated using observable data from other securities presumed to be similar or other market data on other similar securities (Level 3 inputs). The Corporation’s derivative instruments are interest rate swaps that are similar to those that trade in liquid markets. As such, significant fair value inputs can generally be verified and do not typically involve significant management judgments (Level 2 inputs). The fair value of impaired loans with specific allocations of the allowance for loan losses is generally based on recent real estate appraisals prepared by third-parties. These appraisals may utilize a single valuation approach or a combination of approaches including comparable sales and the income approach. Adjustments are routinely made in the appraisal process by the appraisers to adjust for differences between the comparable sales and income data available. Management also adjusts appraised values based on the length of time that has passed since the appraisal date and other factors. Such adjustments are usually significant and typically result in a Level 3 classification of the inputs for determining fair value. Assets and liabilities measured at fair value on a recurring basis are as follows at March 31, 2020 and December 31, 2019 : Fair Value Measurements at March 31, 2020 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Description Total (Level 1) (Level 2) (Level 3) Assets: Securities Available For Sale: U.S. Government sponsored entities $ 126,066 $ 0 $ 126,066 $ 0 States and political subdivisions 103,292 0 103,292 0 Residential and multi-family mortgage 307,520 0 307,520 0 Corporate notes and bonds 7,622 0 7,622 0 Pooled SBA 25,101 0 25,101 0 Other 981 981 0 0 Total Securities Available For Sale $ 570,582 $ 981 $ 569,601 $ 0 Interest Rate swaps $ 4,461 $ 0 $ 4,461 $ 0 Trading Securities: Corporate equity securities $ 3,699 $ 3,699 $ 0 $ 0 Mutual funds 487 487 0 0 Certificates of deposit 614 614 0 0 Corporate notes and bonds 655 655 0 0 U.S. Government sponsored entities 52 0 52 0 Total Trading Securities $ 5,507 $ 5,455 $ 52 $ 0 Liabilities: Interest rate swaps $ (5,362 ) $ 0 $ (5,362 ) $ 0 Fair Value Measurements at December 31, 2019 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Description Total (Level 1) (Level 2) (Level 3) Assets: Securities Available For Sale: U.S. Government sponsored entities $ 127,094 $ 0 $ 127,094 $ 0 States and political subdivisions 104,363 0 104,363 0 Residential and multi-family mortgage 276,636 0 273,841 2,795 Corporate notes and bonds 8,082 0 8,082 0 Pooled SBA 25,174 0 25,174 0 Other 964 964 0 0 Total Securities Available For Sale $ 542,313 $ 964 $ 538,554 $ 2,795 Interest Rate swaps $ 1,877 $ 0 $ 1,877 $ 0 Trading Securities: Corporate equity securities $ 7,946 $ 7,946 $ 0 $ 0 Mutual funds 807 807 0 0 Certificates of deposit 350 350 0 0 Corporate notes and bonds 655 655 0 0 U.S. Government sponsored entities 51 0 51 0 Total Trading Securities $ 9,809 $ 9,758 $ 51 $ 0 Liabilities: Interest rate swaps $ (2,362 ) $ 0 $ (2,362 ) $ 0 Assets and liabilities measured at fair value on a non-recurring basis are as follows at March 31, 2020 and December 31, 2019 : Fair Value Measurements at March 31, 2020 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Description Total (Level 1) (Level 2) (Level 3) Assets: Impaired loans: Commercial, industrial and agricultural $ 5,627 0 0 $ 5,627 Commercial mortgages $ 10,909 0 0 $ 10,909 Fair Value Measurements at December 31, 2019 Using Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs Description Total (Level 1) (Level 2) (Level 3) Assets: Impaired loans: Commercial, industrial and agricultural $ 2,910 0 0 $ 2,910 Commercial mortgages $ 1,147 0 0 $ 1,147 The estimated fair values of impaired collateral dependent loans such as commercial or residential mortgages are determined primarily through third-party appraisals. When a collateral dependent loan, such as a commercial or residential mortgage loan, becomes impaired, a decision is made regarding whether an updated certified appraisal of the real estate is necessary. This decision is based on various considerations, including the age of the most recent appraisal, the loan-to-value ratio based on the original appraisal, and the condition of the property. Appraised values are discounted to arrive at the estimated selling price of the collateral and a further reduction for estimated costs to sell the property is applied, which results in an amount that is considered to be the estimated fair value. If a loan becomes impaired and the appraisal of related loan collateral is outdated, management applies an appropriate adjustment factor based on its experience with current valuations of similar collateral in determining the loan’s estimated fair value and resulting allowance for loan losses. Third-party appraisals are not customarily obtained in respect of unimpaired loans, unless in management’s view changes in circumstances warrant obtaining an updated appraisal. The following table presents quantitative information about Level 3 fair value measurements for financial instruments measured at fair value on a non-recurring basis at March 31, 2020 : Fair value Valuation Technique Unobservable Inputs Range (Weighted Average) Impaired loans – commercial, industrial and agricultural $5,627 Collateral based measurements Discount to reflect current market conditions and ultimate collectability 0%-100% (22%) Impaired loans – commercial mortgages $10,909 Collateral based measurements Discount to reflect current market conditions and ultimate collectability 25-100% (30%) The following table presents quantitative information about Level 3 fair value measurements for financial instruments measured at fair value on a non-recurring basis at December 31, 2019 : Fair value Valuation Technique Unobservable Inputs Range (Weighted Average) Impaired loans – commercial, industrial and agricultural $2,910 Collateral based measurements Discount to reflect current market conditions and ultimate collectability 0%-60% (54%) Impaired loans – commercial mortgages $1,147 Collateral based measurements Discount to reflect current market conditions and ultimate collectability 25%-100% (52%) Fair Value of Financial Instruments The following table presents the carrying amount and fair value of financial instruments at March 31, 2020 : Carrying Fair Value Measurement Using: Total Amount Level 1 Level 2 Level 3 Fair Value ASSETS Cash and cash equivalents $ 136,341 $ 136,341 $ 0 $ 0 $ 136,341 Securities available for sale 570,582 981 569,601 0 570,582 Trading securities 5,507 5,455 52 0 5,507 Loans held for sale 1,815 0 1,825 0 1,825 Net loans 2,828,745 0 0 2,789,605 2,789,605 FHLB and other restricted interests 27,975 n/a n/a n/a n/a Interest rate swaps 4,461 0 4,461 0 4,461 Accrued interest receivable 11,530 6 3,387 8,137 11,530 LIABILITIES Deposits $ (3,100,216 ) $ (2,675,399 ) $ (437,247 ) $ 0 $ (3,112,646 ) FHLB and other borrowings (225,722 ) 0 (233,544 ) 0 (233,544 ) Subordinated debentures (70,620 ) 0 (62,647 ) 0 (62,647 ) Interest rate swaps (5,362 ) 0 (5,362 ) 0 (5,362 ) Accrued interest payable (1,760 ) 0 (1,760 ) 0 (1,760 ) The following table presents the carrying amount and fair value of financial instruments at December 31, 2019 : Carrying Fair Value Measurement Using: Total Amount Level 1 Level 2 Level 3 Fair Value ASSETS Cash and cash equivalents $ 192,974 $ 192,974 $ 0 $ 0 $ 192,974 Securities available for sale 542,313 964 538,554 2,795 542,313 Trading securities 9,809 9,758 51 0 9,809 Loans held for sale 930 0 933 0 933 Net loans 2,784,562 0 0 2,765,133 2,765,133 FHLB and other restricted interests 27,868 n/a n/a n/a n/a Interest rate swaps 1,877 0 1,877 0 1,877 Accrued interest receivable 11,486 6 3,238 8,242 11,486 LIABILITIES Deposits $ (3,102,327 ) $ (2,674,511 ) $ (432,287 ) $ 0 $ (3,106,798 ) FHLB and other borrowings (227,907 ) 0 (230,679 ) 0 (230,679 ) Subordinated debentures (70,620 ) 0 (64,084 ) 0 (64,084 ) Interest rate swaps (2,362 ) 0 (2,632 ) 0 (2,632 ) Accrued interest payable (1,597 ) 0 (1,597 ) 0 (1,597 ) While estimates of fair value are based on management’s judgment of the most appropriate factors as of the balance sheet date, there is no assurance that the estimated fair values would have been realized if the assets had been disposed of or the liabilities settled at that date, since market values may differ depending on various circumstances. The estimated fair values would also not apply to subsequent dates. The fair value of other equity interests is based on the net asset values provided by the underlying investment partnership. ASU 2015-7 removes the requirement to categorize within the fair value hierarchy all investments measured using the net asset value per share practical expedient and related disclosures. In addition, other assets and liabilities that are not financial instruments, such as premises and equipment, are not included in the disclosures. Also, non-financial assets such as, among other things, the estimated earnings power of core deposits, the earnings potential of trust accounts, the trained workforce, and customer goodwill, which typically are not recognized on the balance sheet, may have value but are not included in the fair value disclosures.

Revenue from Contracts with Cus

Revenue from Contracts with Customers	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Revenue from Contracts with Customers	REVENUE FROM CONTRACTS WITH CUSTOMERS All of the Corporation’s revenue from contracts with customers in the scope of ASC 606 is recognized within Non-Interest Income. The following table presents the Corporation's Non-Interest Income by revenue stream and reportable segment for the three months ended March 31, 2020 and 2019 . Items outside the scope of ASC 606 are noted as such. Three months ended March 31, 2020 2019 Non-interest Income Service charges on deposit accounts $ 1,527 $ 1,481 Wealth and asset management fees 1,293 1,042 Mortgage banking (1) 337 239 Card processing and interchange income 1,128 1,029 Net gains (losses) on sales of securities (1) 0 148 Other income 1,079 2,214 Total non-interest income $ 5,364 $ 6,153 (1) Not within scope of ASU 2014-9 Management determined that the primary sources of revenue emanating from interest and dividend income on loans and investment securities along with non-interest revenue resulting from security gains, loan servicing, gains on the sale of loans, commitment fees, fees from financial guarantees, certain credit card fees, gains (losses) on sale of other real estate owned not financed by the Corporation, is not within the scope of ASU 2014-9. The types of non-interest income within the scope of the standard that are material to the consolidated financial statements are services charges on deposit accounts, wealth and asset management fee income, card processing and interchange income, and other income. Service charges on deposit accounts : The Corporation earns fees from its deposit customers for transaction-based, account maintenance, and overdraft services. Transaction-based fees, which include services such as ATM use fees, stop payment charges, statement rendering, and ACH fees, are recognized at the time the transaction is executed, as that is the point in time the Corporation fulfills the customer’s request. Account maintenance fees, which relate primarily to monthly maintenance, are earned over the course of a month, representing the period over which the Corporation satisfies the performance obligation. Overdraft fees are recognized at the point in time that the overdraft occurs. Services charges on deposits are withdrawn from the customer’s account balance. Wealth and asset management fees : The Corporation earns wealth and asset management fees from its contracts with trust and brokerage customers to manage assets for investment, and/or to transact on their accounts. These fees are primarily earned over time as the Corporation provides the contracted monthly or quarterly services and are generally assessed based on a tiered scale of the market value of assets under management at month end. Fees for these services are billed to customers on a monthly or quarterly basis and are recorded as revenue at the end of the period for which the wealth and asset management services have been performed. Other performance obligations, such as the delivery of account statements to customers, are generally considered immaterial to the overall transaction price. Card processing and interchange income : The Corporation earns interchange fees from check card and credit card transactions conducted through the Visa payment network. Interchange fees from cardholder transactions represent a percentage of the underlying transaction value and are recognized daily, concurrently with the transaction processing services provided to the cardholder. Other income

Recent Accounting Pronounceme_2

Recent Accounting Pronouncements (Policies)	3 Months Ended
	Mar. 31, 2020
Accounting Changes and Error Corrections [Abstract]
Recent Accounting Pronouncements	RECENT ACCOUNTING PRONOUNCEMENTS In June 2016, the FASB issued an Accounting Standards Update ("ASU") 2016-13, "Financial Instruments – Credit Losses" which will require recognition of an entity’s current estimate of all expected credit losses for assets measured at amortized cost. The amendment requires the measurement of all expected credit losses for financial assets held at the reporting date, based on historical credit loss experience, current market conditions, and reasonable and supportable forecast. This eliminates the probable initial recognition threshold in current GAAP. The update will be effective for interim and annual reporting periods beginning after December 15, 2019, with early adoption permitted for interim and annual reporting periods beginning after December 15, 2018. In November 2018, the FASB issued ASU 2018-19, "Codification Improvements to Topic 326, Financial Instruments – Credit Losses." The amendment clarifies that receivables arising from operating leases are not within the scope of Subtopic 326-20 and should be accounted for in accordance with Topic 842, "Leases." In April 2019, ASU 2019-04, “Codification Improvements to Topic 326, Financial Instruments—Credit Losses, Topic 815, Derivatives and Hedging, and Topic 825, Financial Instruments,” was issued to address certain codification improvements and to provide certain accounting policy electives related to accrued interest as well as disclosure related to credit losses, among other things. In May 2019, ASU 2019-05, “Financial Instruments—Credit Losses (Topic 326): Targeted Transition Relief,” was issued to provide transition relief in connection with the adoption of ASU 2016-03 whereby entities would have the option to irrevocably elect the fair value option for certain financial assets previously measured at amortized cost basis. The CARES Act provides financial institutions with the option to delay the adoption of ASU No. 2016-13, “Financial Instruments – Credit Losses,” until the earlier of December 31, 2020 or until the national emergency related to the COVID-19 pandemic is terminated. Given the complexity of the processes necessary to properly evaluate, document and implement the current expected credit losses methodology, combined with the extraneous circumstances impacted on its employees, caused by the spread of the coronavirus, the Corporation opted to delay the adoption of ASU No. 2016-13 and recorded its provision for loan losses under the incurred loss model that existed prior to ASU 2016-13. Prior to passage of the CARES Act, based upon the Corporation's fourth quarter parallel run, assessment of the composition, characteristics and credit quality of the Corporation's loan and investment securities portfolio, as well as the economic conditions in effect as of the adoption date, management estimates the adoption of ASU 2016-13 will result in an increase of approximately 20-30% to the Corporation's allowance for credit losses, as reported in its Annual Report Form 10-K for the fiscal year ended December 31, 2019. The adjustment to record the allowance for credit losses may fall outside of management’s estimated increase based on completion of the Corporation's evaluation of qualitative factors and forecasts adjustments to estimate expected credit losses inherent in the loan portfolio. In January 2017, the FASB issued ASU 2017-04, “Intangibles - Goodwill and Other (Topic 350) - Simplifying the Test for Goodwill Impairment” (“ASU 2017-04”). ASU 2017-04 simplifies the accounting for goodwill impairment for all entities by requiring impairment charges to be based on the first step in the previous two-step impairment test. Under the new guidance, if a reporting unit’s carrying amount exceeds its fair value, an entity will record an impairment charge based on that difference. The impairment charge will be limited to the amount of goodwill allocated to that reporting unit. The standard eliminates the prior requirement to calculate a goodwill impairment charge using Step 2, which requires an entity to calculate any impairment charge by comparing the implied fair value of goodwill with its carrying amount. ASU 2017-04 was effective for the Corporation on January 1, 2020 and did not have a material impact on the Corporation's financial statements. In August 2018, the FASB issued ASU 2018-13, “Fair Value Measurement (Topic 820): Disclosure Framework - Changes to the Disclosure Requirements for Fair Value Measurement.” ASU 2018-13 modifies disclosure requirements on fair value measurements based on the concepts in the Concepts Statement, including the consideration of costs and benefits. The amendments on changes in unrealized gains and losses, the range and weighted average of significant unobservable inputs used to develop Level 3 fair value measurements, and the narrative description of measurement uncertainty should be applied prospectively for only the most recent interim or annual period presented in the initial fiscal year of adoption. All other amendments should be applied retrospectively to all periods presented upon their effective date. ASU 2018-13 was effective for the Corporation on January 1, 2020 and did not have a material impact on the Corporation's financial statement disclosures. In August 2018, the FASB issued ASU 2018-14, "Disclosure Framework - Changes to the Disclosure Requirements for Defined Benefit Plans." ASU 2018-14 amends ASC 715-20, "Compensation - Retirement Benefits - Defined Benefit Plans - General." The amended guidance modifies the disclosure requirements for employers that sponsor defined benefit pension or other post-retirement plans by removing and adding certain disclosures for these plans. The eliminated disclosures include (a) the amounts in accumulated Other Comprehensive Income ("OCI") expected to be recognized in net periodic benefit costs over the next fiscal year, and (b) the effects of a one percentage point change in assumed health care cost trend rates on the net periodic benefit costs and the benefit obligation for post-retirement health care benefits. Additional disclosures include descriptions of significant gains and losses affecting the benefit obligation for the period. ASU 2018-14 was effective for the Corporation on January 1, 2020 and did not have a material impact on the Corporation's financial statement disclosures. In August 2018, the FASB issued ASU 2018-15, “Intangibles - Goodwill and Other - Internal-Use Software (Subtopic 350-40) - Customer’s Accounting for Implementation Costs Incurred in a Cloud Computing Arrangement That Is a Service Contract” (“ASU 2018-15”). ASU 2018-15 aligns the requirements for capitalizing implementation costs incurred in a hosting arrangement that is a service contract with the requirements for capitalizing implementation costs incurred to develop or obtain internal-use software (and hosting arrangements that include an internal use software license). The accounting for the service element of a hosting arrangement that is a service contract is not affected by these amendments. ASU 2018-15 was effective for the Corporation on January 1, 2020 and did not have a material impact on the Corporation's financial statements. In March 2020, the FASB issued ASU No. 2020-04, "Reference Rate Reform (Topic 848): Facilitation of the Effects of Reference Rate Reform on Financial Reporting." The amendments in this update provide optional guidance for a limited period of time to ease the potential burden in accounting for (or recognizing the effects of) reference rate reform on financial reporting. It provides optional expedients and exceptions for applying generally accepted accounting principles to contracts, hedging relationships, and other transactions affected by reference rate reform if certain criteria are met. The amendments in this update are effective for all entities as of March 12, 2020 through December 31, 2022. The Corporation is currently evaluating the impact of the reference rate reform on the Corporation's consolidated financial statements. In March 2020, various regulatory agencies, including the Board of Governors of the Federal Reserve System (the "Federal Reserve") and the Federal Deposit Insurance Corporation (the "FDIC”) issued an interagency statement on loan modifications and reporting for financial institutions working with customers affected by the COVID-19 pandemic. The interagency statement was effective immediately and impacted accounting for loan modifications. Under Accounting Standards Codification 310-40, “Receivables - Troubled Debt Restructurings by Creditors” (“ASC 310-40”), a restructuring of debt constitutes a troubled debt restructuring (“TDR”) if the creditor, for economic or legal reasons related to the debtor’s financial difficulties, grants a concession to the debtor that it would not otherwise consider. The agencies confirmed with the staff of the FASB that short-term modifications made on a good faith basis in response to the COVID-19 pandemic to borrowers who were current prior to any relief, are not to be considered TDRs. This includes short-term (e.g., six months) modifications such as payment deferrals, fee waivers, extensions of repayment terms, or other delays in payment that are insignificant. Borrowers considered current are those that are less than 30 days past due on their contractual payments at the time a modification program is implemented. See Note 1 of the footnotes to the consolidated financial statements for disclosure of the impact to date.

Securities (Tables)

Securities (Tables)	3 Months Ended
	Mar. 31, 2020
Investments, Debt and Equity Securities [Abstract]
Securities Available for Sale	Securities available for sale at March 31, 2020 and December 31, 2019 are as follows: March 31, 2020 December 31, 2019 Amortized Unrealized Fair Amortized Unrealized Fair Cost Gains Losses Value Cost Gains Losses Value U.S. Gov’t sponsored entities $ 119,158 $ 6,908 $ 0 $ 126,066 $ 124,189 $ 2,924 $ (19 ) $ 127,094 State & political subdivisions 99,926 3,664 (298 ) 103,292 101,177 3,288 (102 ) 104,363 Residential & multi-family mortgage 295,695 12,052 (227 ) 307,520 273,404 4,117 (885 ) 276,636 Corporate notes & bonds 8,350 12 (740 ) 7,622 8,350 14 (282 ) 8,082 Pooled SBA 24,168 933 0 25,101 25,063 274 (163 ) 25,174 Other 1,020 0 (39 ) 981 1,020 0 (56 ) 964 Total $ 548,317 $ 23,569 $ (1,304 ) $ 570,582 $ 533,203 $ 10,617 $ (1,507 ) $ 542,313
Trading Securities	Trading securities at March 31, 2020 and December 31, 2019 are as follows: March 31, 2020 December 31, 2019 Corporate equity securities $ 3,699 $ 7,946 Mutual funds 487 807 Certificates of deposit 614 350 Corporate notes and bonds 655 655 U.S. Government sponsored entities 52 51 Total $ 5,507 $ 9,809
Securities with Unrealized Losses Aggregated by Investment Category and Length of Time that Individual Securities have been in Continuous Unrealized Loss Position	Securities with unrealized losses at March 31, 2020 and December 31, 2019 , aggregated by investment category and length of time that individual securities have been in a continuous unrealized loss position, are as follows: March 31, 2020 Less than 12 Months 12 Months or More Total Description of Securities Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. Gov’t sponsored entities $ 0 $ 0 $ 0 $ 0 $ 0 $ 0 State & political subdivisions 3,761 (111 ) 682 (187 ) 4,443 (298 ) Residential & multi-family mortgage 2,382 (63 ) 2,822 (164 ) 5,204 (227 ) Corporate notes & bonds 0 0 4,848 (740 ) 4,848 (740 ) Pooled SBA 0 0 0 0 0 0 Other 0 0 981 (39 ) 981 (39 ) $ 6,143 $ (174 ) $ 9,333 $ (1,130 ) $ 15,476 $ (1,304 ) December 31, 2019 Less than 12 Months 12 Months or More Total Fair Value Unrealized Loss Fair Value Unrealized Loss Fair Value Unrealized Loss U.S. Gov’t sponsored entities $ 7,040 $ (3 ) $ 14,989 $ (16 ) $ 22,029 $ (19 ) State & political subdivisions 826 (5 ) 684 (97 ) 1,510 (102 ) Residential & multi-family mortgage 41,841 (346 ) 32,555 (539 ) 74,396 (885 ) Corporate notes & bonds 0 0 4,718 (282 ) 4,718 (282 ) Pooled SBA 8,560 (80 ) 6,075 (83 ) 14,635 (163 ) Other 0 0 964 (56 ) 964 (56 ) $ 58,267 $ (434 ) $ 59,985 $ (1,073 ) $ 118,252 $ (1,507 )
Information Pertaining to Security Sales	Information pertaining to security sales on available for sale securities is as follows: Proceeds Gross Gains Gross Losses Three months ended March 31, 2020 $ 0 $ 0 $ 0 Three months ended March 31, 2019 $ 11,403 $ 152 $ 4
Schedule of Contractual Maturity of Securities Available for Sale, Excluding Equity Securities	The following is a schedule of the contractual maturity of securities available for sale at March 31, 2020 : Amortized Cost Fair Value 1 year or less $ 64,728 $ 64,979 1 year – 5 years 90,138 93,743 5 years – 10 years 65,049 70,592 After 10 years 7,519 7,666 227,434 236,980 Residential & multi-family mortgage 295,695 307,520 Pooled SBA 24,168 25,101 Other 1,020 981 Total debt securities $ 548,317 $ 570,582

Loans (Tables)

Loans (Tables)	3 Months Ended
	Mar. 31, 2020
Receivables [Abstract]
Schedule of Net Loans	Total net loans at March 31, 2020 and December 31, 2019 are summarized as follows: March 31, 2020 December 31, 2019 Commercial, industrial and agricultural $ 1,090,915 $ 1,046,665 Commercial mortgages 846,215 814,002 Residential real estate 814,657 814,030 Consumer 94,425 124,785 Credit cards 8,683 7,569 Overdrafts 311 2,146 Less: unearned discount (4,546 ) (5,162 ) allowance for loan losses (21,915 ) (19,473 ) Loans, net $ 2,828,745 $ 2,784,562
Allowance for Loan Losses	Transactions in the allowance for loan losses for the three months ended March 31, 2020 were as follows: Commercial,Industrial Commercial Mortgages Residential Real Estate Consumer Credit Cards Overdrafts Total Allowance for loan losses, January 1, 2020 $ 8,287 $ 6,952 $ 1,499 $ 2,411 $ 84 $ 240 $ 19,473 Charge-offs (25 ) 0 (143 ) (592 ) (31 ) (119 ) (910 ) Recoveries 18 172 3 43 1 36 273 Provision (benefit) for loan losses 2,252 368 99 276 58 26 3,079 Allowance for loan losses, March 31, 2020 $ 10,532 $ 7,492 $ 1,458 $ 2,138 $ 112 $ 183 $ 21,915 Transactions in the allowance for loan losses for the three months ended March 31, 2019 were as follows: Commercial, Industrial and Agricultural Commercial Mortgages Residential Real Estate Consumer Credit Cards Overdrafts Total Allowance for loan losses, January 1, 2019 $ 7,341 $ 7,490 $ 2,156 $ 2,377 $ 103 $ 237 $ 19,704 Charge-offs 0 (17 ) (98 ) (549 ) (26 ) (128 ) (818 ) Recoveries 4 0 65 46 5 34 154 Provision (benefit) for loan losses 442 1,373 (740 ) 166 23 42 1,306 Allowance for loan losses, March 31, 2019 $ 7,787 $ 8,846 $ 1,383 $ 2,040 $ 105 $ 185 $ 20,346
Allowance for Loan Losses and Recorded Investment in Loans by Portfolio Segment	The following table presents the balance in the allowance for loan losses and the recorded investment in loans by portfolio segment and is based on the Corporation’s impairment method as of March 31, 2020 and December 31, 2019 . The recorded investment in loans excludes accrued interest and unearned discounts due to their insignificance. March 31, 2020 Commercial, Industrial and Agricultural Commercial Mortgages Residential Real Estate Consumer Credit Cards Overdrafts Total Allowance for loan losses: Ending allowance balance attributable to loans: Individually evaluated for impairment $ 3,489 $ 1,264 $ 51 $ 0 $ 0 $ 0 $ 4,804 Collectively evaluated for impairment 7,009 5,912 1,407 2,138 112 183 16,761 Acquired with deteriorated credit quality 0 0 0 0 0 0 0 Modified in a troubled debt restructuring 34 316 0 0 0 0 350 Total ending allowance balance $ 10,532 $ 7,492 $ 1,458 $ 2,138 $ 112 $ 183 $ 21,915 Loans: Individually evaluated for impairment $ 8,663 $ 12,172 $ 460 $ 0 $ 0 $ 0 $ 21,295 Collectively evaluated for impairment 1,079,220 826,966 814,197 94,425 8,683 311 2,823,802 Acquired with deteriorated credit quality 0 512 0 0 0 0 512 Modified in a troubled debt restructuring 3,032 6,565 0 0 0 0 9,597 Total ending loans balance $ 1,090,915 $ 846,215 $ 814,657 $ 94,425 $ 8,683 $ 311 $ 2,855,206 December 31, 2019 Commercial, Industrial and Agricultural Commercial Mortgages Residential Real Estate Consumer Credit Cards Overdrafts Total Allowance for loan losses: Ending allowance balance attributable to loans: Individually evaluated for impairment $ 645 $ 1,264 $ 34 $ 0 $ 0 $ 0 $ 1,943 Collectively evaluated for impairment 7,614 5,358 1,465 2,411 84 240 17,172 Acquired with deteriorated credit quality 0 0 0 0 0 0 0 Modified in a troubled debt restructuring 28 330 0 0 0 0 358 Total ending allowance balance $ 8,287 $ 6,952 $ 1,499 $ 2,411 $ 84 $ 240 $ 19,473 Loans: Individually evaluated for impairment $ 8,078 $ 2,410 $ 465 $ 0 $ 0 $ 0 $ 10,953 Collectively evaluated for impairment 1,035,494 804,360 813,565 124,785 7,569 2,146 2,787,919 Acquired with deteriorated credit quality 0 523 0 0 0 0 523 Modified in a troubled debt restructuring 3,093 6,709 0 0 0 0 9,802 Total ending loans balance $ 1,046,665 $ 814,002 $ 814,030 $ 124,785 $ 7,569 $ 2,146 $ 2,809,197
Loans Individually Evaluated for Impairment Including Loans Modified in Troubled Debt Restructurings by Portfolio Segment	The following tables present information related to loans individually evaluated for impairment, including loans modified in troubled debt restructurings, by portfolio segment as of March 31, 2020 and December 31, 2019 and for the three months ended March 31, 2020 and 2019 : March 31, 2020 Unpaid Principal Balance Recorded Investment Allowance for Loan Losses Allocated With an allowance recorded: Commercial, industrial and agricultural $ 7,111 $ 7,068 $ 3,523 Commercial mortgage 6,542 4,312 1,580 Residential real estate 480 460 51 With no related allowance recorded: Commercial, industrial and agricultural 4,780 4,627 0 Commercial mortgage 14,666 14,425 0 Residential real estate 0 0 0 Total $ 33,579 $ 30,892 $ 5,154 December 31, 2019 Unpaid Principal Balance Recorded Investment Allowance for Loan Losses Allocated With an allowance recorded: Commercial, industrial and agricultural $ 2,657 $ 1,476 $ 673 Commercial mortgage 6,541 4,349 1,594 Residential real estate 485 465 34 With no related allowance recorded: Commercial, industrial and agricultural 9,845 9,695 0 Commercial mortgage 4,903 4,770 0 Residential real estate 0 0 0 Total $ 24,431 $ 20,755 $ 2,301
Impaired Financing Receivables with Related and not Related Allowances	The unpaid principal balance of impaired loans includes the Corporation’s recorded investment in the loan and amounts that have been charged off. Three months ended March 31, 2020 Three months ended March 31, 2019 Average Interest Cash Basis Average Interest Cash Basis With an allowance recorded: Commercial, industrial and agricultural $ 4,272 $ 17 $ 17 $ 2,158 $ 38 $ 38 Commercial mortgage 4,331 37 37 7,267 40 40 Residential real estate 463 5 5 0 0 0 With no related allowance recorded: Commercial, industrial and agricultural 7,161 42 42 3,376 54 54 Commercial mortgage 9,598 158 158 4,065 18 18 Residential real estate 0 0 0 500 7 7 Total $ 25,825 $ 259 $ 259 $ 17,366 $ 157 $ 157
Nonaccrual Loans and Loans Past Due over 90 Days Still Accruing Interest by Class of Loans	The following table presents the recorded investment in nonaccrual loans and loans past due over 90 days still on accrual by class of loans as of March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 Nonaccrual Past Due Over 90 Days Still on Accrual Nonaccrual Past Due Over 90 Days Still on Accrual Commercial, industrial and agricultural $ 12,144 $ 16 $ 11,644 $ 0 Commercial mortgages 14,237 0 4,533 0 Residential real estate 4,663 0 4,724 59 Consumer 810 0 835 0 Credit cards 0 17 0 2 Total $ 31,854 $ 33 $ 21,736 $ 61
Aging of Recorded Investment in Past Due Loans	The following table presents the aging of the recorded investment in past due loans as of March 31, 2020 and December 31, 2019 by class of loans. March 31, 2020 30-59 Days Past Due 60-89 Days Past Due Greater Than 89 Days Past Due Total Past Due Loans Not Past Due Total Commercial, industrial and agricultural $ 2,604 $ 6,251 $ 4,809 $ 13,664 $ 1,077,251 $ 1,090,915 Commercial mortgages 11,773 179 2,599 14,551 831,664 846,215 Residential real estate 3,285 623 2,601 6,509 808,148 814,657 Consumer 450 238 433 1,121 93,304 94,425 Credit cards 33 33 17 83 8,600 8,683 Overdrafts 0 0 0 0 311 311 Total $ 18,145 $ 7,324 $ 10,459 $ 35,928 $ 2,819,278 $ 2,855,206 December 31, 2019 30-59 Days Past Due 60-89 Days Past Due Greater Than 89 Days Past Due Total Past Due Loans Not Past Due Total Commercial, industrial and agricultural $ 1,273 $ 548 $ 3,784 $ 5,605 $ 1,041,060 $ 1,046,665 Commercial mortgages 162 183 2,594 2,939 811,063 814,002 Residential real estate 3,383 1,270 2,714 7,367 806,663 814,030 Consumer 412 311 415 1,138 123,647 124,785 Credit cards 48 54 2 104 7,465 7,569 Overdrafts 0 0 0 0 2,146 2,146 Total $ 5,278 $ 2,366 $ 9,509 $ 17,153 $ 2,792,044 $ 2,809,197
Restructured in Troubled Debt	The following table presents the number of loans, loan balances, and specific reserves for loans that have been restructured in a troubled debt restructuring as of March 31, 2020 and December 31, 2019 . March 31, 2020 December 31, 2019 Number of Loans Loan Balance Specific Reserve Number of Loans Loan Balance Specific Reserve Commercial, industrial and agricultural 10 $ 3,032 $ 34 10 $ 3,093 $ 28 Commercial mortgages 13 6,565 316 13 6,709 330 Residential real estate 0 0 0 0 0 0 Consumer 0 0 0 0 0 0 Credit cards 0 0 0 0 0 0 Total 23 $ 9,597 $ 350 23 $ 9,802 $ 358
Schedule of Loan Assigned Risk Rating within 12 Months of Balance Sheet Date	March 31, 2020 Pass Special Mention Substandard Doubtful Total Commercial, industrial and agricultural $ 1,049,414 $ 13,444 $ 28,057 $ 0 $ 1,090,915 Commercial mortgages 799,848 22,388 23,979 0 846,215 Total $ 1,849,262 $ 35,832 $ 52,036 $ 0 $ 1,937,130 December 31, 2019 Pass Special Mention Substandard Doubtful Total Commercial, industrial and agricultural $ 1,004,445 $ 16,696 $ 25,524 $ 0 $ 1,046,665 Commercial mortgages 780,798 18,837 14,367 0 814,002 Total $ 1,785,243 $ 35,533 $ 39,891 $ 0 $ 1,860,667
Recorded Investment in Residential, Consumer and Credit Card Loans Based on Payment Activity	The following table presents the recorded investment in residential, consumer, and credit card loans based on payment activity as of March 31, 2020 and December 31, 2019 : March 31, 2020 December 31, 2019 Residential Real Estate Consumer Credit Cards Residential Real Estate Consumer Credit Cards Performing $ 809,994 $ 93,615 $ 8,666 $ 809,247 $ 123,950 $ 7,567 Nonperforming 4,663 810 17 4,783 835 2 Total $ 814,657 $ 94,425 $ 8,683 $ 814,030 $ 124,785 $ 7,569
Summary of Holiday's Loan Portfolio	Holiday’s loan portfolio is summarized as follows at March 31, 2020 and December 31, 2019 : 3/31/2020 12/31/2019 Consumer $ 25,855 $ 28,122 Less: unearned discount (4,546 ) (5,162 ) Total $ 21,309 $ 22,960

Leases (Tables)

Leases (Tables)	3 Months Ended
	Mar. 31, 2020
Leases [Abstract]
Schedule Of Operating And Finance Lease Liabilities	Leases Classification March 31, 2020 December 31, 2019 Assets: Operating lease assets Operating lease assets $ 18,360 $ 18,422 Finance lease assets Premises and equipment, net (1) 483 501 Total leased assets $ 18,843 $ 18,923 Liabilities: Operating lease liabilities Operating lease liabilities $ 19,397 $ 19,363 Finance lease liabilities Accrued interest payable and other liabilities 609 629 Total leased liabilities $ 20,006 $ 19,992 (1) Finance lease assets are recorded net of accumulated amortization of $733 as of March 31, 2020 and $715 as of December 31, 2019.
Schedule Of Lease Cost	Other Information March 31, 2020 March 31, 2019 Cash paid for amounts included in the measurement of lease liabilities Operating cash flows from operating leases $ 212 $ 192 The components of the Corporation's net lease expense for the three months ended March 31, 2020 and 2019, respectively, were as follows: Three months ended March 31, Lease Cost Classification 2020 2019 Operating lease cost Net occupancy expense $ 455 $ 405 Variable lease cost Net occupancy expense 24 34 Finance lease cost: Amortization of leased assets Net occupancy expense 18 18 Interest on lease liabilities Interest expense - borrowed funds 7 8 Sublease income (1) Net occupancy expense (21 ) (21 ) Net lease cost $ 483 $ 444 (1) Sublease income excludes rental income from owned properties.
Finance Lease, Liability, Maturity	The following table sets forth future minimum rental payments under noncancelable leases with terms in excess of one year as of March 31, 2020 : Maturity of Lease Liabilities as of March 31, 2020 Operating Leases (1) Finance Leases Total 2020 $ 1,209 $ 79 $ 1,288 2021 1,636 105 1,741 2022 1,682 105 1,787 2023 1,572 105 1,677 2024 1,538 105 1,643 After 2024 19,373 210 19,583 Total lease payments 27,010 709 27,719 Less: Interest 7,613 100 7,713 Present value of lease liabilities $ 19,397 $ 609 $ 20,006
Lessee, Operating Lease, Liability, Maturity	The following table sets forth future minimum rental payments under noncancelable leases with terms in excess of one year as of March 31, 2020 : Maturity of Lease Liabilities as of March 31, 2020 Operating Leases (1) Finance Leases Total 2020 $ 1,209 $ 79 $ 1,288 2021 1,636 105 1,741 2022 1,682 105 1,787 2023 1,572 105 1,677 2024 1,538 105 1,643 After 2024 19,373 210 19,583 Total lease payments 27,010 709 27,719 Less: Interest 7,613 100 7,713 Present value of lease liabilities $ 19,397 $ 609 $ 20,006
Schedule of Weighted Average Lease Term and Discount Rate	Other information related to the Corporation's lease liabilities as of the three months ended March 31, 2020 and 2019, respectively, were as follows: Lease Term and Discount Rate March 31, 2020 March 31, 2019 Weighted-average remaining lease term (years) Operating leases 18.4 17.3 Finance leases 6.8 7.8 Weighted-average discount rate Operating leases 3.52 % 3.66 % Finance leases 4.49 % 4.54 %

Deposits (Tables)

Deposits (Tables)	3 Months Ended
	Mar. 31, 2020
Banking and Thrift [Abstract]
Total Deposits	Total deposits at March 31, 2020 and December 31, 2019 are summarized as follows: 3/31/2020 12/31/2019 Percentage Checking, non-interest bearing $ 376,840 $ 382,259 (1.4 )% Checking, interest bearing 617,864 628,579 (1.7 )% Savings accounts 1,680,695 1,663,673 1.0 % Certificates of deposit 424,817 427,816 (0.7 )% Total $ 3,100,216 $ 3,102,327 (0.1 )%

Stock Compensation (Tables)

Stock Compensation (Tables)	3 Months Ended
	Mar. 31, 2020
Share-based Payment Arrangement [Abstract]
Summary of Changes in Nonvested Restricted Stock Awards	A summary of changes in time-based nonvested restricted stock awards for the three months ended March 31, 2020 follows: Shares Per Share Weighted Average Grant Date Fair Value Nonvested at beginning of period 58,370 $ 24.96 Granted 23,658 29.56 Vested (26,262 ) 24.08 Nonvested at end of period 55,766 $ 27.42

Earnings Per Share (Tables)

Earnings Per Share (Tables)	3 Months Ended
	Mar. 31, 2020
Earnings Per Share [Abstract]
Computation of Basic and Diluted Earnings Per Share	The computation of basic and diluted earnings per share is shown below: Three months ended March 31, 2020 2019 Basic earnings per common share computation: Net income per consolidated statements of income $ 8,813 $ 9,473 Net earnings allocated to participating securities (30 ) (39 ) Net earnings allocated to common stock $ 8,783 $ 9,434 Distributed earnings allocated to common stock $ 2,608 $ 2,579 Undistributed earnings allocated to common stock 6,175 6,855 Net earnings allocated to common stock $ 8,783 $ 9,434 Weighted average common shares outstanding, including shares considered participating securities 15,333 15,229 Less: Average participating securities (52 ) (62 ) Weighted average shares 15,281 15,167 Basic earnings per common share $ 0.57 $ 0.62 Diluted earnings per common share computation: Net earnings allocated to common stock $ 8,783 $ 9,434 Weighted average common shares outstanding for basic earnings per common share 15,281 15,167 Add: Dilutive effects of assumed exercises of stock options 0 0 Weighted average shares and dilutive potential common shares 15,281 15,167 Diluted earnings per common share $ 0.57 $ 0.62

Derivative Instruments (Tables)

Derivative Instruments (Tables)	3 Months Ended
	Mar. 31, 2020
Derivative Instruments and Hedging Activities Disclosure [Abstract]
Amounts and Locations of Activity Related to Interest Rate Swaps Designated as Cash Flow Hedges within Corporation's Consolidated Balance Sheet and Statement of Income	The following tables provide information about the amounts and locations of activity related to the interest rate swaps designated as cash flow hedges within the Corporation’s consolidated balance sheet and statement of income as of March 31, 2020 and December 31, 2019 and for the three months ended March 31, 2020 and 2019 : Fair value as of Balance Sheet Location March 31, 2020 December 31, 2019 Interest rate contracts Accrued interest and other liabilities $ (901 ) $ (485 ) For the Three Months (a) (b) (c) (d) (e) Interest rate contracts $ (329 ) Interest expense – $ (21 ) Other $ 0 For the Three Months (a) (b) (c) (d) (e) Interest rate contracts $ (95 ) Interest expense – $ (6 ) Other $ 0 (a) Amount of Gain or (Loss) Recognized in Other Comprehensive Loss on Derivative (Effective Portion), net of tax (b) Location of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income (Effective Portion) (c) Amount of Gain or (Loss) Reclassified from Accumulated Other Comprehensive Loss into Income (Effective Portion) (d) Location of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded from Effectiveness Testing) (e) Amount of Gain or (Loss) Recognized in Income on Derivative (Ineffective Portion and Amount Excluded from Effectiveness Testing)
Amounts and Locations of Activity Related to Back-to-Back Interest Rate Swaps within Corporation's Consolidated Balance Sheet	The following table provides information about the amounts and locations of activity related to the back-to-back interest rate swaps within the Corporation’s consolidated balance sheet as of March 31, 2020 and December 31, 2019 : Notional Amount Weighted Average Maturity (in years) Weighted Average Fixed Rate Weighted Average Variable Rate Fair Value March 31, 2020 3rd Party interest rate swaps $ 35,061 7.5 4.13 % 1 month LIBOR + 2.27% $ 4,461 (a) Customer interest rate swaps (35,061 ) 7.5 4.13 % 1 month LIBOR + 2.27% (4,461 ) (b) December 31, 2019 3rd Party interest rate swaps $ 35,382 7.7 4.13 % 1 month LIBOR + 2.27 $ 1,877 (a) Customer interest rate swaps (35,382 ) 7.7 4.13 % 1 month LIBOR + 2.27 (1,877 ) (b) (a) Reported in accrued interest receivable and other assets within the consolidated balance sheets (b) Reported in accrued interest payable and other liabilities within the consolidated balance sheets

Fair Value (Tables)

Fair Value (Tables)	3 Months Ended
	Mar. 31, 2020
Fair Value Disclosures [Abstract]
Assets and Liabilities Measured at Fair Value on Recurring Basis	Assets and liabilities measured at fair value on a recurring basis are as follows at March 31, 2020 and December 31, 2019 : Fair Value Measurements at March 31, 2020 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Description Total (Level 1) (Level 2) (Level 3) Assets: Securities Available For Sale: U.S. Government sponsored entities $ 126,066 $ 0 $ 126,066 $ 0 States and political subdivisions 103,292 0 103,292 0 Residential and multi-family mortgage 307,520 0 307,520 0 Corporate notes and bonds 7,622 0 7,622 0 Pooled SBA 25,101 0 25,101 0 Other 981 981 0 0 Total Securities Available For Sale $ 570,582 $ 981 $ 569,601 $ 0 Interest Rate swaps $ 4,461 $ 0 $ 4,461 $ 0 Trading Securities: Corporate equity securities $ 3,699 $ 3,699 $ 0 $ 0 Mutual funds 487 487 0 0 Certificates of deposit 614 614 0 0 Corporate notes and bonds 655 655 0 0 U.S. Government sponsored entities 52 0 52 0 Total Trading Securities $ 5,507 $ 5,455 $ 52 $ 0 Liabilities: Interest rate swaps $ (5,362 ) $ 0 $ (5,362 ) $ 0 Fair Value Measurements at December 31, 2019 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Description Total (Level 1) (Level 2) (Level 3) Assets: Securities Available For Sale: U.S. Government sponsored entities $ 127,094 $ 0 $ 127,094 $ 0 States and political subdivisions 104,363 0 104,363 0 Residential and multi-family mortgage 276,636 0 273,841 2,795 Corporate notes and bonds 8,082 0 8,082 0 Pooled SBA 25,174 0 25,174 0 Other 964 964 0 0 Total Securities Available For Sale $ 542,313 $ 964 $ 538,554 $ 2,795 Interest Rate swaps $ 1,877 $ 0 $ 1,877 $ 0 Trading Securities: Corporate equity securities $ 7,946 $ 7,946 $ 0 $ 0 Mutual funds 807 807 0 0 Certificates of deposit 350 350 0 0 Corporate notes and bonds 655 655 0 0 U.S. Government sponsored entities 51 0 51 0 Total Trading Securities $ 9,809 $ 9,758 $ 51 $ 0 Liabilities: Interest rate swaps $ (2,362 ) $ 0 $ (2,362 ) $ 0
Assets and Liabilities Measured at Fair Value on Non-Recurring Basis	Assets and liabilities measured at fair value on a non-recurring basis are as follows at March 31, 2020 and December 31, 2019 : Fair Value Measurements at March 31, 2020 Using: Quoted Prices in Active Markets for Identical Assets Significant Other Observable Inputs Significant Unobservable Inputs Description Total (Level 1) (Level 2) (Level 3) Assets: Impaired loans: Commercial, industrial and agricultural $ 5,627 0 0 $ 5,627 Commercial mortgages $ 10,909 0 0 $ 10,909 Fair Value Measurements at December 31, 2019 Using Quoted Prices in Significant Active Markets for Significant Other Unobservable Identical Assets Observable Inputs Inputs Description Total (Level 1) (Level 2) (Level 3) Assets: Impaired loans: Commercial, industrial and agricultural $ 2,910 0 0 $ 2,910 Commercial mortgages $ 1,147 0 0 $ 1,147
Quantitative Information about Level 3 Fair Value Measurements for Financial Instruments Measured at Fair Value on Non Recurring Basis	The following table presents quantitative information about Level 3 fair value measurements for financial instruments measured at fair value on a non-recurring basis at March 31, 2020 : Fair value Valuation Technique Unobservable Inputs Range (Weighted Average) Impaired loans – commercial, industrial and agricultural $5,627 Collateral based measurements Discount to reflect current market conditions and ultimate collectability 0%-100% (22%) Impaired loans – commercial mortgages $10,909 Collateral based measurements Discount to reflect current market conditions and ultimate collectability 25-100% (30%) The following table presents quantitative information about Level 3 fair value measurements for financial instruments measured at fair value on a non-recurring basis at December 31, 2019 : Fair value Valuation Technique Unobservable Inputs Range (Weighted Average) Impaired loans – commercial, industrial and agricultural $2,910 Collateral based measurements Discount to reflect current market conditions and ultimate collectability 0%-60% (54%) Impaired loans – commercial mortgages $1,147 Collateral based measurements Discount to reflect current market conditions and ultimate collectability 25%-100% (52%)
Carrying Amount and Fair Value of Financial Instruments	The following table presents the carrying amount and fair value of financial instruments at March 31, 2020 : Carrying Fair Value Measurement Using: Total Amount Level 1 Level 2 Level 3 Fair Value ASSETS Cash and cash equivalents $ 136,341 $ 136,341 $ 0 $ 0 $ 136,341 Securities available for sale 570,582 981 569,601 0 570,582 Trading securities 5,507 5,455 52 0 5,507 Loans held for sale 1,815 0 1,825 0 1,825 Net loans 2,828,745 0 0 2,789,605 2,789,605 FHLB and other restricted interests 27,975 n/a n/a n/a n/a Interest rate swaps 4,461 0 4,461 0 4,461 Accrued interest receivable 11,530 6 3,387 8,137 11,530 LIABILITIES Deposits $ (3,100,216 ) $ (2,675,399 ) $ (437,247 ) $ 0 $ (3,112,646 ) FHLB and other borrowings (225,722 ) 0 (233,544 ) 0 (233,544 ) Subordinated debentures (70,620 ) 0 (62,647 ) 0 (62,647 ) Interest rate swaps (5,362 ) 0 (5,362 ) 0 (5,362 ) Accrued interest payable (1,760 ) 0 (1,760 ) 0 (1,760 ) The following table presents the carrying amount and fair value of financial instruments at December 31, 2019 : Carrying Fair Value Measurement Using: Total Amount Level 1 Level 2 Level 3 Fair Value ASSETS Cash and cash equivalents $ 192,974 $ 192,974 $ 0 $ 0 $ 192,974 Securities available for sale 542,313 964 538,554 2,795 542,313 Trading securities 9,809 9,758 51 0 9,809 Loans held for sale 930 0 933 0 933 Net loans 2,784,562 0 0 2,765,133 2,765,133 FHLB and other restricted interests 27,868 n/a n/a n/a n/a Interest rate swaps 1,877 0 1,877 0 1,877 Accrued interest receivable 11,486 6 3,238 8,242 11,486 LIABILITIES Deposits $ (3,102,327 ) $ (2,674,511 ) $ (432,287 ) $ 0 $ (3,106,798 ) FHLB and other borrowings (227,907 ) 0 (230,679 ) 0 (230,679 ) Subordinated debentures (70,620 ) 0 (64,084 ) 0 (64,084 ) Interest rate swaps (2,362 ) 0 (2,632 ) 0 (2,632 ) Accrued interest payable (1,597 ) 0 (1,597 ) 0 (1,597 )

Revenue from Contracts with C_2

Revenue from Contracts with Customers (Tables)	3 Months Ended
	Mar. 31, 2020
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue Derived from Contracts with Customers	for the three months ended March 31, 2020 and 2019 . Items outside the scope of ASC 606 are noted as such. Three months ended March 31, 2020 2019 Non-interest Income Service charges on deposit accounts $ 1,527 $ 1,481 Wealth and asset management fees 1,293 1,042 Mortgage banking (1) 337 239 Card processing and interchange income 1,128 1,029 Net gains (losses) on sales of securities (1) 0 148 Other income 1,079 2,214 Total non-interest income $ 5,364 $ 6,153 (1) Not within scope of ASU 2014-9

Basis of Presentation Narrative

Basis of Presentation Narrative (Details)	Apr. 16, 2020USD ($)relationship	Mar. 31, 2020USD ($)loan
Subsequent Event [Line Items]
Deferred loan payment, number of loans | loan		561
Deferred loan payment, period		6 months
Deferred loan payment, amount		$ 264,000,000
Deferred loan payment, number of loans, principal and interest		150
Deferred loan payment, amount, principal and interest		$ 151,000,000
Deferred loan payment, amount, number of loans, principal | loan		411
Deferred loan payment, amount, principal		$ 113,000,000
Subsequent Event
Subsequent Event [Line Items]
PPP, Amount	$ 177,000,000
PPP, Relationship | relationship	1,031
PPP, Interest Rate	1.00%
PPP, Processing Fees	$ 6,000,000

Securities - Securities Availab

Securities - Securities Available for Sale (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Amortized cost
Total debt securities	$ 548,317	$ 533,203
Unrealized Gains (Losses)
Accumulated gross unrealized gain, before tax	23,569	10,617
Accumulated gross unrealized loss, before tax	(1,304)	(1,507)
Amortized Cost
Securities available for sale	570,582	542,313
U.S. Gov’t sponsored entities
Amortized cost
Total debt securities	119,158	124,189
Unrealized Gains (Losses)
Accumulated gross unrealized gain, before tax	6,908	2,924
Accumulated gross unrealized loss, before tax	0	(19)
Amortized Cost
Securities available for sale	126,066	127,094
State & political subdivisions
Amortized cost
Total debt securities	99,926	101,177
Unrealized Gains (Losses)
Accumulated gross unrealized gain, before tax	3,664	3,288
Accumulated gross unrealized loss, before tax	(298)	(102)
Amortized Cost
Securities available for sale	103,292	104,363
Residential & multi-family mortgage
Amortized cost
Total debt securities	295,695	273,404
Unrealized Gains (Losses)
Accumulated gross unrealized gain, before tax	12,052	4,117
Accumulated gross unrealized loss, before tax	(227)	(885)
Amortized Cost
Securities available for sale	307,520	276,636
Corporate notes & bonds
Amortized cost
Total debt securities	8,350	8,350
Unrealized Gains (Losses)
Accumulated gross unrealized gain, before tax	12	14
Accumulated gross unrealized loss, before tax	(740)	(282)
Amortized Cost
Securities available for sale	7,622	8,082
Pooled SBA
Amortized cost
Total debt securities	24,168	25,063
Unrealized Gains (Losses)
Accumulated gross unrealized gain, before tax	933	274
Accumulated gross unrealized loss, before tax	0	(163)
Amortized Cost
Securities available for sale	25,101	25,174
Other
Amortized cost
Total debt securities	1,020	1,020
Unrealized Gains (Losses)
Accumulated gross unrealized gain, before tax	0	0
Accumulated gross unrealized loss, before tax	(39)	(56)
Amortized Cost
Securities available for sale	$ 981	$ 964

Securities - Additional Informa

Securities - Additional Information (Details) $ in Thousands	1 Months Ended	3 Months Ended
	May 07, 2020USD ($)	Mar. 31, 2020USD ($)security	Mar. 31, 2019USD ($)	Dec. 31, 2019USD ($)security
Debt and Equity Securities, FV-NI [Line Items]
Number of securities holdings | security		0		0
Shareholders' equity percentage (greater than)		10.00%		10.00%
Tax provision related to net realized gains		$ 0	$ 31
Proceeds		0	11,403
Net realized gains on available-for-sale securities (includes $0 and $148 accumulated other comprehensive income reclassifications for net realized gains on available-for-sale securities, respectively)		0	148
Gross Gains		0	152
Gross Losses		0	$ 4
Total Securities Available For Sale		570,582		$ 542,313
Collateral Pledged
Debt and Equity Securities, FV-NI [Line Items]
Debt securities, trading, restricted		$ 409,616		$ 405,200
Subsequent Event
Debt and Equity Securities, FV-NI [Line Items]
Proceeds	$ 50,902
Net realized gains on available-for-sale securities (includes $0 and $148 accumulated other comprehensive income reclassifications for net realized gains on available-for-sale securities, respectively)	2,033
Gross Gains	2,100
Gross Losses	$ 67

Securities - Trading Securities

Securities - Trading Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Debt and Equity Securities, FV-NI [Line Items]
Trading securities	$ 5,507	$ 9,809
Corporate equity securities
Debt and Equity Securities, FV-NI [Line Items]
Trading securities	3,699	7,946
Mutual funds
Debt and Equity Securities, FV-NI [Line Items]
Trading securities	487	807
Certificates of deposit
Debt and Equity Securities, FV-NI [Line Items]
Trading securities	614	350
Corporate notes and bonds
Debt and Equity Securities, FV-NI [Line Items]
Trading securities	655	655
U.S. Gov’t sponsored entities
Debt and Equity Securities, FV-NI [Line Items]
Trading securities	$ 52	$ 51

Securities - Securities with Un

Securities - Securities with Unrealized Losses Aggregated by Investment Category and Length of Time that Individual Securities have been in Continuous Unrealized Loss Position (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Less than 12 Months
Fair Value	$ 6,143	$ 58,267
Unrealized Loss	(174)	(434)
12 Months or More
Fair Value	9,333	59,985
Unrealized Loss	(1,130)	(1,073)
Fair Value	15,476	118,252
Unrealized Loss	(1,304)	(1,507)
U.S. Gov’t sponsored entities
Less than 12 Months
Fair Value	0	7,040
Unrealized Loss	0	(3)
12 Months or More
Fair Value	0	14,989
Unrealized Loss	0	(16)
Fair Value	0	22,029
Unrealized Loss	0	(19)
State & political subdivisions
Less than 12 Months
Fair Value	3,761	826
Unrealized Loss	(111)	(5)
12 Months or More
Fair Value	682	684
Unrealized Loss	(187)	(97)
Fair Value	4,443	1,510
Unrealized Loss	(298)	(102)
Residential & multi-family mortgage
Less than 12 Months
Fair Value	2,382	41,841
Unrealized Loss	(63)	(346)
12 Months or More
Fair Value	2,822	32,555
Unrealized Loss	(164)	(539)
Fair Value	5,204	74,396
Unrealized Loss	(227)	(885)
Corporate notes & bonds
Less than 12 Months
Fair Value	0	0
Unrealized Loss	0	0
12 Months or More
Fair Value	4,848	4,718
Unrealized Loss	(740)	(282)
Fair Value	4,848	4,718
Unrealized Loss	(740)	(282)
Pooled SBA
Less than 12 Months
Fair Value	0	8,560
Unrealized Loss	0	(80)
12 Months or More
Fair Value	0	6,075
Unrealized Loss	0	(83)
Fair Value	0	14,635
Unrealized Loss	0	(163)
Other
Less than 12 Months
Fair Value	0	0
Unrealized Loss	0	0
12 Months or More
Fair Value	981	964
Unrealized Loss	(39)	(56)
Fair Value	981	964
Unrealized Loss	$ (39)	$ (56)

Securities - Schedule of Contra

Securities - Schedule of Contractual Maturity of Securities Available for Sale, Excluding Equity Securities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Amortized Cost
1 year or less	$ 64,728
1 year – 5 years	90,138
5 years – 10 years	65,049
After 10 years	7,519
Total, Amortized Cost	227,434
Total debt securities	548,317	$ 533,203
Fair Value
1 year or less	64,979
1 year – 5 years	93,743
5 years – 10 years	70,592
After 10 years	7,666
Total, Fair Value	236,980
Total debt securities	570,582	542,313
Residential & multi-family mortgage
Amortized Cost
Mortgage & asset backed securities, Amortized Cost	295,695
Total debt securities	295,695	273,404
Fair Value
Mortgage & asset backed securities, Fair Value	307,520
Total debt securities	307,520	276,636
Pooled SBA
Amortized Cost
Mortgage & asset backed securities, Amortized Cost	24,168
Total debt securities	24,168	25,063
Fair Value
Mortgage & asset backed securities, Fair Value	25,101
Total debt securities	25,101	25,174
Other
Amortized Cost
Mortgage & asset backed securities, Amortized Cost	1,020
Total debt securities	1,020	1,020
Fair Value
Mortgage & asset backed securities, Fair Value	981
Total debt securities	$ 981	$ 964

Securities - Information Pertai

Securities - Information Pertaining to Security Sales (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Investments, Debt and Equity Securities [Abstract]
Proceeds	$ 0	$ 11,403
Gross Gains	0	152
Gross Losses	$ 0	$ 4

Business Combinations (Detail)

Business Combinations (Detail) $ / shares in Units, $ in Thousands	Sep. 30, 2020USD ($)$ / shares	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)	Mar. 31, 2019USD ($)	Dec. 31, 2018USD ($)
Business Acquisition [Line Items]
Assets		$ 3,779,138	$ 3,763,659
Deposits		3,100,216	3,102,327
Stockholders' equity		$ 324,802	$ 304,966	$ 274,959	$ 262,830
Scenario, Forecast | Bank of Akron
Business Acquisition [Line Items]
Share price (in dollars per share) | $ / shares	$ 215
Share conversion ratio	6.6729
Percentage of shares exchanged	75.00%
Bank of Akron | Scenario, Forecast
Business Acquisition [Line Items]
Assets	$ 388,500
Deposits	341,400
Stockholders' equity	$ 38,700

Loans - Schedule of Net Loans (

Loans - Schedule of Net Loans (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Loan Portfolio By Loan Grade [Line Items]
Loans and leases receivable, gross	$ 2,855,206	$ 2,809,197
Less: unearned discount	(4,546)	(5,162)
allowance for loan losses	(21,915)	(19,473)	$ (20,346)	$ (19,704)
Net loans	2,828,745	2,784,562
Commercial, industrial and agricultural
Loan Portfolio By Loan Grade [Line Items]
Loans and leases receivable, gross	1,090,915	1,046,665
allowance for loan losses	(10,532)	(8,287)	(7,787)	(7,341)
Net loans	1,090,915	1,046,665
Commercial mortgages
Loan Portfolio By Loan Grade [Line Items]
Loans and leases receivable, gross	846,215	814,002
allowance for loan losses	(7,492)	(6,952)	(8,846)	(7,490)
Net loans	846,215	814,002
Residential real estate
Loan Portfolio By Loan Grade [Line Items]
Loans and leases receivable, gross	814,657	814,030
allowance for loan losses	(1,458)	(1,499)	(1,383)	(2,156)
Net loans	814,657	814,030
Consumer
Loan Portfolio By Loan Grade [Line Items]
Loans and leases receivable, gross	94,425	124,785
allowance for loan losses	(2,138)	(2,411)	(2,040)	(2,377)
Net loans	94,425	124,785
Credit cards
Loan Portfolio By Loan Grade [Line Items]
Loans and leases receivable, gross	8,683	7,569
allowance for loan losses	(112)	(84)	(105)	(103)
Net loans	8,683	7,569
Overdrafts
Loan Portfolio By Loan Grade [Line Items]
Loans and leases receivable, gross	311	2,146
allowance for loan losses	$ (183)	$ (240)	$ (185)	$ (237)

Loans - Additional Information

Loans - Additional Information (Details)	3 Months Ended		12 Months Ended
	Mar. 31, 2020USD ($)loan	Mar. 31, 2019USD ($)loan	Dec. 31, 2019USD ($)
Accounts, Notes, Loans and Financing Receivable [Line Items]
Net unamortized loan fees	$ 3,267,000		$ 3,092,000
Percentage of comprised loan, commercial, industrial and agricultural loans	38.00%		37.00%
Percentage of comprised loan, commercial mortgage loans	30.00%		29.00%
Percentage of loan-to-value to business equipment	80.00%
Percentage of loan-to-value to accounts receivable	70.00%
Percentage of loan-to-value to business inventory	60.00%
Percentage of loan-to-value to real estate	85.00%
Percentage of residential real estate loan in portfolio	29.00%		29.00%
Minimum period to be considered for loan to have defaulted	90 days		90 days
Loans modified as troubled debt restructuring with subsequent defaults | loan	0	0
Principal balances forgiven in connection with loan restructuring	$ 0		$ 0
Number of loans, period of time | loan	0	0
Modified in a troubled debt restructuring	$ 9,597,000		$ 9,802,000
Financing receivable, allowance for credit losses, w-downs	$ 910,000	$ 818,000
Maximum
Accounts, Notes, Loans and Financing Receivable [Line Items]
Maximum percentage of consumer loan and credit card in portfolio	4.00%		4.00%

Loans - Allowance for Loan Loss

Loans - Allowance for Loan Losses (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for loan losses, Beginning Balance	$ 19,473	$ 19,704
Charge-offs	(910)	(818)
Recoveries	273	154
Provision (benefit) for loan losses	3,079	1,306
Allowance for loan losses, Ending Balance	21,915	20,346
Commercial, industrial and agricultural
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for loan losses, Beginning Balance	8,287	7,341
Charge-offs	(25)	0
Recoveries	18	4
Provision (benefit) for loan losses	2,252	442
Allowance for loan losses, Ending Balance	10,532	7,787
Commercial Mortgages
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for loan losses, Beginning Balance	6,952	7,490
Charge-offs	0	(17)
Recoveries	172	0
Provision (benefit) for loan losses	368	1,373
Allowance for loan losses, Ending Balance	7,492	8,846
Residential real estate
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for loan losses, Beginning Balance	1,499	2,156
Charge-offs	(143)	(98)
Recoveries	3	65
Provision (benefit) for loan losses	99	(740)
Allowance for loan losses, Ending Balance	1,458	1,383
Consumer
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for loan losses, Beginning Balance	2,411	2,377
Charge-offs	(592)	(549)
Recoveries	43	46
Provision (benefit) for loan losses	276	166
Allowance for loan losses, Ending Balance	2,138	2,040
Credit cards
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for loan losses, Beginning Balance	84	103
Charge-offs	(31)	(26)
Recoveries	1	5
Provision (benefit) for loan losses	58	23
Allowance for loan losses, Ending Balance	112	105
Overdrafts
Financing Receivable, Allowance for Credit Loss [Roll Forward]
Allowance for loan losses, Beginning Balance	240	237
Charge-offs	(119)	(128)
Recoveries	36	34
Provision (benefit) for loan losses	26	42
Allowance for loan losses, Ending Balance	$ 183	$ 185

Loans - Allowance for Loan Lo_2

Loans - Allowance for Loan Losses and Recorded Investment in Loans by Portfolio Segment (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019	Mar. 31, 2019	Dec. 31, 2018
Ending allowance balance attributable to loans:
Individually evaluated for impairment	$ 4,804	$ 1,943
Collectively evaluated for impairment	16,761	17,172
Modified in a troubled debt restructuring	350	358
Total ending allowance balance	21,915	19,473	$ 20,346	$ 19,704
Loans:
Individually evaluated for impairment	21,295	10,953
Collectively evaluated for impairment	2,823,802	2,787,919
Modified in a troubled debt restructuring, collective pool	9,597
Modified in a troubled debt restructuring	9,597	9,802
Total ending loans balance	2,855,206	2,809,197
Acquired with deteriorated credit quality
Ending allowance balance attributable to loans:
Total ending allowance balance	0	0
Loans:
Total ending loans balance	512	523
Commercial, Industrial and Agricultural
Ending allowance balance attributable to loans:
Individually evaluated for impairment	3,489	645
Collectively evaluated for impairment	7,009	7,614
Modified in a troubled debt restructuring	34	28
Total ending allowance balance	10,532	8,287	7,787	7,341
Loans:
Individually evaluated for impairment	8,663	8,078
Collectively evaluated for impairment	1,079,220	1,035,494
Modified in a troubled debt restructuring, collective pool	3,032
Modified in a troubled debt restructuring	3,032	3,093
Total ending loans balance	1,090,915	1,046,665
Commercial, Industrial and Agricultural | Acquired with deteriorated credit quality
Ending allowance balance attributable to loans:
Total ending allowance balance	0	0
Loans:
Total ending loans balance	0	0
Commercial mortgages
Ending allowance balance attributable to loans:
Individually evaluated for impairment	1,264	1,264
Collectively evaluated for impairment	5,912	5,358
Modified in a troubled debt restructuring	316	330
Total ending allowance balance	7,492	6,952	8,846	7,490
Loans:
Individually evaluated for impairment	12,172	2,410
Collectively evaluated for impairment	826,966	804,360
Modified in a troubled debt restructuring, collective pool	6,565
Modified in a troubled debt restructuring	6,565	6,709
Total ending loans balance	846,215	814,002
Commercial mortgages | Acquired with deteriorated credit quality
Ending allowance balance attributable to loans:
Total ending allowance balance	0	0
Loans:
Total ending loans balance	512	523
Residential Real Estate
Ending allowance balance attributable to loans:
Individually evaluated for impairment	51	34
Collectively evaluated for impairment	1,407	1,465
Modified in a troubled debt restructuring	0	0
Total ending allowance balance	1,458	1,499	1,383	2,156
Loans:
Individually evaluated for impairment	460	465
Collectively evaluated for impairment	814,197	813,565
Modified in a troubled debt restructuring, collective pool	0
Modified in a troubled debt restructuring	0	0
Total ending loans balance	814,657	814,030
Residential Real Estate | Acquired with deteriorated credit quality
Ending allowance balance attributable to loans:
Total ending allowance balance	0	0
Loans:
Total ending loans balance	0	0
Consumer
Ending allowance balance attributable to loans:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	2,138	2,411
Modified in a troubled debt restructuring	0	0
Total ending allowance balance	2,138	2,411	2,040	2,377
Loans:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	94,425	124,785
Modified in a troubled debt restructuring, collective pool	0
Modified in a troubled debt restructuring	0	0
Total ending loans balance	94,425	124,785
Consumer | Acquired with deteriorated credit quality
Ending allowance balance attributable to loans:
Total ending allowance balance	0	0
Loans:
Total ending loans balance	0	0
Credit Cards
Ending allowance balance attributable to loans:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	112	84
Modified in a troubled debt restructuring	0	0
Total ending allowance balance	112	84	105	103
Loans:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	8,683	7,569
Modified in a troubled debt restructuring, collective pool	0
Modified in a troubled debt restructuring	0	0
Total ending loans balance	8,683	7,569
Credit Cards | Acquired with deteriorated credit quality
Ending allowance balance attributable to loans:
Total ending allowance balance	0	0
Loans:
Total ending loans balance	0	0
Overdrafts
Ending allowance balance attributable to loans:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	183	240
Modified in a troubled debt restructuring	0	0
Total ending allowance balance	183	240	$ 185	$ 237
Loans:
Individually evaluated for impairment	0	0
Collectively evaluated for impairment	311	2,146
Modified in a troubled debt restructuring, collective pool	0
Modified in a troubled debt restructuring		0
Total ending loans balance	311	2,146
Overdrafts | Acquired with deteriorated credit quality
Ending allowance balance attributable to loans:
Total ending allowance balance	0	0
Loans:
Total ending loans balance	$ 0	$ 0

Loans - Loans Individually Eval

Loans - Loans Individually Evaluated for Impairment Including Loans Modified in Troubled Debt Restructurings by Portfolio Segment (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
With an allowance recorded:
Allowance for Loan Losses Allocated	$ 5,154	$ 2,301
With no related allowance recorded:
Unpaid Principal Balance, Total	33,579	24,431
Recorded Investment, Total	30,892	20,755
Commercial, industrial and agricultural
With an allowance recorded:
Unpaid Principal Balance	7,111	2,657
Recorded Investment	7,068	1,476
Allowance for Loan Losses Allocated	3,523	673
With no related allowance recorded:
Unpaid Principal Balance	4,780	9,845
Recorded Investment	4,627	9,695
Commercial mortgages
With an allowance recorded:
Unpaid Principal Balance	6,542	6,541
Recorded Investment	4,312	4,349
Allowance for Loan Losses Allocated	1,580	1,594
With no related allowance recorded:
Unpaid Principal Balance	14,666	4,903
Recorded Investment	14,425	4,770
Residential Real Estate
With an allowance recorded:
Unpaid Principal Balance	480	485
Recorded Investment	460	465
Allowance for Loan Losses Allocated	51	34
With no related allowance recorded:
Unpaid Principal Balance	0	0
Recorded Investment	$ 0	$ 0

Loans - Impaired Financing Rece

Loans - Impaired Financing Receivables with Related and not Related Allowances (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
With no related allowance recorded:
Average Recorded Investment, Total	$ 25,825	$ 17,366
Interest Income Recognized, Total	259	157
Cash Basis Interest Recognized, Total	259	157
Commercial, industrial and agricultural
With an allowance recorded:
Average Recorded Investment	4,272	2,158
Interest Income Recognized	17	38
Cash Basis Interest Recognized	17	38
With no related allowance recorded:
Average Recorded Investment	7,161	3,376
Interest Income Recognized	42	54
Cash Basis Interest Recognized	42	54
Commercial mortgages
With an allowance recorded:
Average Recorded Investment	4,331	7,267
Interest Income Recognized	37	40
Cash Basis Interest Recognized	37	40
With no related allowance recorded:
Average Recorded Investment	9,598	4,065
Interest Income Recognized	158	18
Cash Basis Interest Recognized	158	18
Residential real estate
With an allowance recorded:
Average Recorded Investment	463	0
Interest Income Recognized	5	0
Cash Basis Interest Recognized	5	0
With no related allowance recorded:
Average Recorded Investment	0	500
Interest Income Recognized	0	7
Cash Basis Interest Recognized	$ 0	$ 7

Loans - Nonaccrual Loans and Lo

Loans - Nonaccrual Loans and Loans Past Due over 90 Days Still Accruing Interest by Class of Loans (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Financing Receivable, Past Due [Line Items]
Nonaccrual	$ 31,854	$ 21,736
Past Due Over 90 Days Still on Accrual	33	61
Commercial, industrial and agricultural
Financing Receivable, Past Due [Line Items]
Nonaccrual	12,144	11,644
Past Due Over 90 Days Still on Accrual	16	0
Commercial mortgages
Financing Receivable, Past Due [Line Items]
Nonaccrual	14,237	4,533
Past Due Over 90 Days Still on Accrual	0	0
Residential real estate
Financing Receivable, Past Due [Line Items]
Nonaccrual	4,663	4,724
Past Due Over 90 Days Still on Accrual	0	59
Consumer
Financing Receivable, Past Due [Line Items]
Nonaccrual	810	835
Past Due Over 90 Days Still on Accrual	0	0
Credit Cards
Financing Receivable, Past Due [Line Items]
Nonaccrual	0	0
Past Due Over 90 Days Still on Accrual	$ 17	$ 2

Loans - Aging of Recorded Inves

Loans - Aging of Recorded Investment in Past Due Loans (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Financing Receivable, Past Due [Line Items]
Total Past Due	$ 35,928	$ 17,153
Loans Not Past Due	2,819,278	2,792,044
Total ending loans balance	2,855,206	2,809,197
30-59 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	18,145	5,278
60-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	7,324	2,366
Greater Than 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	10,459	9,509
Commercial, Industrial and Agricultural
Financing Receivable, Past Due [Line Items]
Total Past Due	13,664	5,605
Loans Not Past Due	1,077,251	1,041,060
Total ending loans balance	1,090,915	1,046,665
Commercial, Industrial and Agricultural | 30-59 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	2,604	1,273
Commercial, Industrial and Agricultural | 60-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	6,251	548
Commercial, Industrial and Agricultural | Greater Than 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	4,809	3,784
Commercial mortgages
Financing Receivable, Past Due [Line Items]
Total Past Due	14,551	2,939
Loans Not Past Due	831,664	811,063
Total ending loans balance	846,215	814,002
Commercial mortgages | 30-59 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	11,773	162
Commercial mortgages | 60-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	179	183
Commercial mortgages | Greater Than 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	2,599	2,594
Residential real estate
Financing Receivable, Past Due [Line Items]
Total Past Due	6,509	7,367
Loans Not Past Due	808,148	806,663
Total ending loans balance	814,657	814,030
Residential real estate | 30-59 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	3,285	3,383
Residential real estate | 60-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	623	1,270
Residential real estate | Greater Than 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	2,601	2,714
Consumer
Financing Receivable, Past Due [Line Items]
Total Past Due	1,121	1,138
Loans Not Past Due	93,304	123,647
Total ending loans balance	94,425	124,785
Consumer | 30-59 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	450	412
Consumer | 60-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	238	311
Consumer | Greater Than 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	433	415
Credit cards
Financing Receivable, Past Due [Line Items]
Total Past Due	83	104
Loans Not Past Due	8,600	7,465
Total ending loans balance	8,683	7,569
Credit cards | 30-59 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	33	48
Credit cards | 60-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	33	54
Credit cards | Greater Than 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	17	2
Overdrafts
Financing Receivable, Past Due [Line Items]
Total Past Due	0	0
Loans Not Past Due	311	2,146
Total ending loans balance	311	2,146
Overdrafts | 30-59 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	0	0
Overdrafts | 60-89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	0	0
Overdrafts | Greater Than 89 Days Past Due
Financing Receivable, Past Due [Line Items]
Total Past Due	$ 0	$ 0

Loans - Restructured in Trouble

Loans - Restructured in Troubled Debt (Details) $ in Thousands	3 Months Ended
	Mar. 31, 2020USD ($)loan	Mar. 31, 2019loan	Dec. 31, 2019USD ($)loan
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of loans at a point in time | loan	23		23
Loan Balance	$ 9,597		$ 9,802
Specific Reserve	$ 350		$ 358
Number of loans, period of time | loan	0	0
Commercial, industrial and agricultural
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of loans at a point in time | loan	10		10
Loan Balance	$ 3,032		$ 3,093
Specific Reserve	$ 34		$ 28
Commercial mortgages
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of loans at a point in time | loan	13		13
Loan Balance	$ 6,565		$ 6,709
Specific Reserve	$ 316		$ 330
Residential real estate
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of loans at a point in time | loan	0		0
Loan Balance	$ 0		$ 0
Specific Reserve	$ 0		$ 0
Consumer
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of loans at a point in time | loan	0		0
Loan Balance	$ 0		$ 0
Specific Reserve	$ 0		$ 0
Credit cards
Financing Receivable, Troubled Debt Restructuring [Line Items]
Number of loans at a point in time | loan	0		0
Loan Balance	$ 0		$ 0
Specific Reserve	$ 0		$ 0

Loans - Schedule of Loan Assign

Loans - Schedule of Loan Assigned Risk Rating within 12 Months of Balance Sheet Date (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	$ 2,828,745	$ 2,784,562
Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	1,849,262	1,785,243
Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	35,832	35,533
Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	52,036	39,891
Doubtful
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	0	0
Pass, Special Mention, Substandard, Doubtful
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	1,937,130	1,860,667
Commercial, industrial and agricultural
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	1,090,915	1,046,665
Commercial, industrial and agricultural | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	1,049,414	1,004,445
Commercial, industrial and agricultural | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	13,444	16,696
Commercial, industrial and agricultural | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	28,057	25,524
Commercial, industrial and agricultural | Doubtful
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	0	0
Commercial mortgages
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	846,215	814,002
Commercial mortgages | Pass
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	799,848	780,798
Commercial mortgages | Special Mention
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	22,388	18,837
Commercial mortgages | Substandard
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	23,979	14,367
Commercial mortgages | Doubtful
Financing Receivable, Credit Quality Indicator [Line Items]
Net loans	$ 0	$ 0

Loans - Recorded Investment in

Loans - Recorded Investment in Residential, Consumer and Credit Card Loans Based on Payment Activity (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Financing Receivable, Credit Quality Indicator [Line Items]
Financing receivable, net	$ 2,828,745	$ 2,784,562
Residential real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Financing receivable, net	814,657	814,030
Consumer
Financing Receivable, Credit Quality Indicator [Line Items]
Financing receivable, net	94,425	124,785
Credit cards
Financing Receivable, Credit Quality Indicator [Line Items]
Financing receivable, net	8,683	7,569
Performing | Residential real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Financing receivable, net	809,994	809,247
Performing | Consumer
Financing Receivable, Credit Quality Indicator [Line Items]
Financing receivable, net	93,615	123,950
Performing | Credit cards
Financing Receivable, Credit Quality Indicator [Line Items]
Financing receivable, net	8,666	7,567
Nonperforming | Residential real estate
Financing Receivable, Credit Quality Indicator [Line Items]
Financing receivable, net	4,663	4,783
Nonperforming | Consumer
Financing Receivable, Credit Quality Indicator [Line Items]
Financing receivable, net	810	835
Nonperforming | Credit cards
Financing Receivable, Credit Quality Indicator [Line Items]
Financing receivable, net	$ 17	$ 2

Loans - Summary of Holiday's Lo

Loans - Summary of Holiday's Loan Portfolio (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Accounts, Notes, Loans and Financing Receivable [Line Items]
Consumer	$ 2,855,206	$ 2,809,197
Less: unearned discount	3,267	3,092
Net loans	2,828,745	2,784,562
Holiday Financial Services Corporation | Residential Real Estate And Consumer
Accounts, Notes, Loans and Financing Receivable [Line Items]
Consumer	25,855	28,122
Less: unearned discount	(4,546)	(5,162)
Net loans	$ 21,309	$ 22,960

Leases - Narrative (Details)

Leases - Narrative (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Leases [Abstract]
Operating lease assets	$ 18,360	$ 18,422
Operating lease liabilities	$ 19,397	$ 19,363

Leases - Schedule of Operating

Leases - Schedule of Operating and Finance Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Assets:
Operating lease assets	$ 18,360	$ 18,422
Finance lease assets	483	501
Total leased assets	18,843	18,923
Liabilities:
Operating lease liabilities	19,397	19,363
Finance lease liabilities	609	629
Total leased liabilities	20,006	19,992
Finance lease, net of accumulated amortization	$ 733	$ 715

Leases - Schedule of Lease Cost

Leases - Schedule of Lease Cost (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Operating lease cost	$ 455	$ 405
Variable lease cost	24	34
Finance lease cost:
Amortization of leased assets	18	18
Interest on lease liabilities	7	8
Sublease income	(21)	(21)
Net lease cost	$ 483	$ 444

Leases - Schedule of Maturity o

Leases - Schedule of Maturity of Lease Liabilities (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Operating Leases
2020	$ 1,209
2021	1,636
2022	1,682
2023	1,572
2024	1,538
After 2024	19,373
Total lease payments	27,010
Less: Interest	7,613
Operating lease liabilities	19,397	$ 19,363
Finance Leases
2020	79
2021	105
2022	105
2023	105
2024	105
After 2024	210
Total lease payments	709
Less: Interest	100
Present value of lease liabilities	609	$ 629
Total
2020	1,288
2021	1,741
2022	1,787
2023	1,677
2024	1,643
After 2024	19,583
Total lease payments	27,719
Less: Interest	7,713
Present value of lease liabilities	$ 20,006

Leases - Schedule of Weighted A

Leases - Schedule of Weighted Average Lease Term and Discount Rate (Details)	Mar. 31, 2020	Mar. 31, 2019
Weighted-average remaining lease term (years)
Operating leases	18 years 4 months 24 days	17 years 3 months 18 days
Finance leases	6 years 9 months 18 days	7 years 9 months 18 days
Weighted-average discount rate
Operating leases	3.52%	3.66%
Finance leases	4.49%	4.54%

Leases Leases- Other Informatio

Leases Leases- Other Information (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Leases [Abstract]
Operating cash flows from operating leases	$ 212	$ 192

Deposits (Details)

Deposits (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
Banking and Thrift [Abstract]
Checking, non-interest bearing	$ 376,840	$ 382,259
Checking, interest bearing	617,864	628,579
Savings accounts	1,680,695	1,663,673
Certificates of deposit	424,817	427,816
Total deposits	$ 3,100,216	$ 3,102,327
Percentage Change, Checking, non-interest bearing	(1.40%)
Percentage Change, Checking, interest bearing	(1.70%)
Percentage Change, Savings accounts	1.00%
Percentage Change, Certificates of deposit	(0.70%)
Percentage Change	(0.10%)

Stock Compensation - Additional

Stock Compensation - Additional Information (Details) - USD ($)	3 Months Ended		12 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019	Dec. 31, 2018
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation cost related to nonvested stock options granted	$ 0	$ 0
Shares, granted (in shares)	0	0
Compensation expense restricted stock awards	$ 549,000	$ 592,000
Fair value of shares vesting during period	$ 1,101,000	1,227,000
Performance Based Restricted Stock Awards | Maximum
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares, granted (in shares)	18,100		16,681	15,657
Restricted Stock Units (RSUs)
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares vested (in shares)	26,262
Unrecognized compensation cost related to nonvested restricted stock	$ 1,562,000		$ 1,026,000
Income tax benefit related to share based compensation	$ 115,000	$ 124,000
Vested, shares (in shares)	23,658
Weighted average grant (in dollars per share)	$ 29.56
Restricted Stock Units (RSUs) | Vested Immediately
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Compensation expense restricted stock awards	$ 340,000
Key Employees
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Starting period of vesting of stock based award	1 year
Aggregate percentage of stock based awards to be matured	100.00%
Key Employees | Vesting in year two
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock incentive plan, vesting per year	25.00%
Key Employees | Vesting in year three
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock incentive plan, vesting per year	20.00%
Independent Directors
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Starting period of vesting of stock based award	1 year
Aggregate percentage of stock based awards to be matured	100.00%
Independent Directors | Vesting in year one
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock incentive plan, vesting per year	33.33%
Restricted Stock
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Vested, shares (in shares)	11,502
Weighted average grant (in dollars per share)	$ 29.56

Stock Compensation - Summary of

Stock Compensation - Summary of Changes in Time-based Nonvested Restricted Stock Awards (Details) - Restricted Stock Units (RSUs)	3 Months Ended
	Mar. 31, 2020$ / sharesshares
Shares
Nonvested at beginning of period, Shares (in shares) | shares	58,370
Granted, shares (in shares) | shares	23,658
Vested, Shares (in shares) | shares	(26,262)
Nonvested at end of period, Shares (in shares) | shares	55,766
Per Share Weighted Average Grant Date Fair Value
Nonvested at beginning of period, Weighted-average Grant Date Fair Value (in dollars per share) | $ / shares	$ 24.96
Granted, Weighted-average Grant Date Fair Value (in dollars per share) | $ / shares	29.56
Vested, Weighted-average Grant Date Fair Value (in dollars per share) | $ / shares	24.08
Nonvested at end of period, Weighted-average Grant Date Fair Value (in dollars per share) | $ / shares	$ 27.42

Earnings Per Share - Additional

Earnings Per Share - Additional Information (Details) - shares	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Earnings Per Share [Abstract]
Dilutive effects of assumed exercises of stock options (in shares)	0	0

Earnings Per Share - Computatio

Earnings Per Share - Computation of Basic and Diluted Earnings Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Basic earnings per common share computation:
Net income per consolidated statements of income	$ 8,813	$ 9,473
Net earnings allocated to participating securities	(30)	(39)
Net earnings allocated to common stock	$ 8,783	$ 9,434
Weighted average common shares outstanding, including shares considered participating securities (in shares)	15,333,000	15,229,000
Less: Average participating securities (in shares)	(52,000)	(62,000)
Weighted average shares (in shares)	15,281,000	15,167,000
Basic earnings per common share (in dollar per share)	$ 0.57	$ 0.62
Diluted earnings per common share computation:
Net earnings allocated to common stock	$ 8,783	$ 9,434
Weighted average common shares outstanding for basic earnings per common share (in shares)	15,281,000	15,167,000
Add: Dilutive effects of assumed exercises of stock options (in shares)	0	0
Weighted average shares and dilutive potential common shares (in shares)	15,281,000	15,167,000
Diluted earnings per common share (in dollar per share)	$ 0.57	$ 0.62
Distributed earnings allocated to common stock
Basic earnings per common share computation:
Net earnings allocated to common stock	$ 2,608	$ 2,579
Undistributed earnings allocated to common stock
Basic earnings per common share computation:
Net earnings allocated to common stock	$ 6,175	$ 6,855

Derivative Instruments - Additi

Derivative Instruments - Additional Information (Details) - USD ($)	Sep. 07, 2018	Mar. 31, 2020	Dec. 31, 2019
Schedule Of Loans And Allowance For Loan By Class Individually And Collectively Evaluated For Impairment [Line Items]
Derivatives designated as fair value hedges		$ 0	$ 0
Accumulated other comprehensive loss estimated		229,000
Collateral amount for counterparty interest rate swap		$ 1,050,000	750,000
2.98% Fixed Rate Plus 155 Basis Points
Schedule Of Loans And Allowance For Loan By Class Individually And Collectively Evaluated For Impairment [Line Items]
Interest rate being paid by the corporation		4.53%
Interest Rate Swaps
Schedule Of Loans And Allowance For Loan By Class Individually And Collectively Evaluated For Impairment [Line Items]
Cash collateral pledged		$ 4,400,000	$ 2,000,000
Unsecured Debt
Schedule Of Loans And Allowance For Loan By Class Individually And Collectively Evaluated For Impairment [Line Items]
Term of contract	5 years
Cash flow hedges	$ 10,000,000
Unsecured Debt | LIBOR Plus 155 Basis Points
Schedule Of Loans And Allowance For Loan By Class Individually And Collectively Evaluated For Impairment [Line Items]
Variable interest rate on subordinate debt		2.29%
Unsecured Debt | 2.98% Fixed Rate Plus 155 Basis Points
Schedule Of Loans And Allowance For Loan By Class Individually And Collectively Evaluated For Impairment [Line Items]
Derivative fixed interest rate rate basis		2.98%
London Interbank Offered Rate (LIBOR) | Unsecured Debt | LIBOR Plus 155 Basis Points
Schedule Of Loans And Allowance For Loan By Class Individually And Collectively Evaluated For Impairment [Line Items]
Basis spread on variable rate		155.00%
London Interbank Offered Rate (LIBOR) | Unsecured Debt | 2.98% Fixed Rate Plus 155 Basis Points
Schedule Of Loans And Allowance For Loan By Class Individually And Collectively Evaluated For Impairment [Line Items]
Basis spread on variable rate		155.00%

Derivative Instruments - Amount

Derivative Instruments - Amounts and Locations of Activity Related to Interest Rate Swaps Designated as Cash Flow Hedges within Corporation's Consolidated Balance Sheet and Statement of Income (Details) - Interest Rate Swaps - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019	Dec. 31, 2019
Derivative [Line Items]
Interest rate contracts	$ (329)	$ (95)
Accrued interest and other liabilities
Derivative [Line Items]
Accrued interest and other liabilities	(901)		$ (485)
Interest expense – subordinated debentures
Derivative [Line Items]
Other income	(21)	(6)
Other income
Derivative [Line Items]
Other income	$ 0	$ 0

Derivative Instruments - Amou_2

Derivative Instruments - Amounts and Locations of Activity Related to Back-to-Back Interest Rate Swaps within Corporation's Consolidated Balance Sheet (Details) - USD ($) $ in Thousands	3 Months Ended	12 Months Ended
	Mar. 31, 2020	Dec. 31, 2019
3rd Party interest rate swaps
Schedule Of Loans And Allowance For Loan By Class Individually And Collectively Evaluated For Impairment [Line Items]
Notional Amount	$ 35,061	$ 35,382
Weighted Average Maturity (in years)	7 years 6 months	7 years 8 months 12 days
Weighted Average Fixed Rate	4.13%	4.13%
Fair Value	$ 4,461	$ 1,877
Customer interest rate swaps
Schedule Of Loans And Allowance For Loan By Class Individually And Collectively Evaluated For Impairment [Line Items]
Derivative Liability, Notional Amount	$ (35,061)	$ (35,382)
Weighted Average Maturity (in years)	7 years 6 months	7 years 8 months 12 days
Weighted Average Fixed Rate	4.13%	4.13%
Fair Value	$ (4,461)	$ (1,877)
London Interbank Offered Rate (LIBOR) | 3rd Party interest rate swaps
Schedule Of Loans And Allowance For Loan By Class Individually And Collectively Evaluated For Impairment [Line Items]
Basis spread on variable rate	2.27%	2.27%
London Interbank Offered Rate (LIBOR) | Customer interest rate swaps
Schedule Of Loans And Allowance For Loan By Class Individually And Collectively Evaluated For Impairment [Line Items]
Basis spread on variable rate	2.27%	2.27%

Fair Value - Assets and Liabili

Fair Value - Assets and Liabilities Measured at Fair Value on Recurring Basis (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Securities Available For Sale:
Total Securities Available For Sale	$ 570,582	$ 542,313
Fair Value Measurement on Recurring Basis
Securities Available For Sale:
Total Securities Available For Sale	570,582	542,313
Interest Rate swaps	4,461	1,877
Trading Securities:
Total Trading Securities	5,507	9,809
Liabilities:
Interest rate swaps	(5,362)	(2,362)
Fair Value Measurement on Recurring Basis | Quoted Prices in Active Markets for Identical Assets
Securities Available For Sale:
Total Securities Available For Sale	981	964
Interest Rate swaps	0	0
Trading Securities:
Total Trading Securities	5,455	9,758
Liabilities:
Interest rate swaps	0	0
Fair Value Measurement on Recurring Basis | Significant Other Observable Inputs
Securities Available For Sale:
Total Securities Available For Sale	569,601	538,554
Interest Rate swaps	4,461	1,877
Trading Securities:
Total Trading Securities	52	51
Liabilities:
Interest rate swaps	(5,362)	(2,362)
Fair Value Measurement on Recurring Basis | Significant Unobservable Inputs
Securities Available For Sale:
Total Securities Available For Sale	0	2,795
Interest Rate swaps	0	0
Trading Securities:
Total Trading Securities	0	0
Liabilities:
Interest rate swaps	0	0
U.S. Government sponsored entities
Securities Available For Sale:
Total Securities Available For Sale	126,066	127,094
U.S. Government sponsored entities | Fair Value Measurement on Recurring Basis
Securities Available For Sale:
Total Securities Available For Sale	126,066	127,094
Trading Securities:
Total Trading Securities	52	51
U.S. Government sponsored entities | Fair Value Measurement on Recurring Basis | Quoted Prices in Active Markets for Identical Assets
Securities Available For Sale:
Total Securities Available For Sale	0	0
Trading Securities:
Total Trading Securities	0	0
U.S. Government sponsored entities | Fair Value Measurement on Recurring Basis | Significant Other Observable Inputs
Securities Available For Sale:
Total Securities Available For Sale	126,066	127,094
Trading Securities:
Total Trading Securities	52	51
U.S. Government sponsored entities | Fair Value Measurement on Recurring Basis | Significant Unobservable Inputs
Securities Available For Sale:
Total Securities Available For Sale	0	0
Trading Securities:
Total Trading Securities	0	0
State & political subdivisions
Securities Available For Sale:
Total Securities Available For Sale	103,292	104,363
State & political subdivisions | Fair Value Measurement on Recurring Basis
Securities Available For Sale:
Total Securities Available For Sale	103,292	104,363
State & political subdivisions | Fair Value Measurement on Recurring Basis | Quoted Prices in Active Markets for Identical Assets
Securities Available For Sale:
Total Securities Available For Sale	0	0
State & political subdivisions | Fair Value Measurement on Recurring Basis | Significant Other Observable Inputs
Securities Available For Sale:
Total Securities Available For Sale	103,292	104,363
State & political subdivisions | Fair Value Measurement on Recurring Basis | Significant Unobservable Inputs
Securities Available For Sale:
Total Securities Available For Sale	0	0
Residential and multi-family mortgage
Securities Available For Sale:
Total Securities Available For Sale	307,520	276,636
Residential and multi-family mortgage | Fair Value Measurement on Recurring Basis
Securities Available For Sale:
Total Securities Available For Sale	307,520	276,636
Residential and multi-family mortgage | Fair Value Measurement on Recurring Basis | Quoted Prices in Active Markets for Identical Assets
Securities Available For Sale:
Total Securities Available For Sale	0	0
Residential and multi-family mortgage | Fair Value Measurement on Recurring Basis | Significant Other Observable Inputs
Securities Available For Sale:
Total Securities Available For Sale	307,520	273,841
Residential and multi-family mortgage | Fair Value Measurement on Recurring Basis | Significant Unobservable Inputs
Securities Available For Sale:
Total Securities Available For Sale	0	2,795
Corporate notes and bonds | Fair Value Measurement on Recurring Basis
Securities Available For Sale:
Total Securities Available For Sale	7,622	8,082
Corporate notes and bonds | Fair Value Measurement on Recurring Basis | Quoted Prices in Active Markets for Identical Assets
Securities Available For Sale:
Total Securities Available For Sale	0	0
Corporate notes and bonds | Fair Value Measurement on Recurring Basis | Significant Other Observable Inputs
Securities Available For Sale:
Total Securities Available For Sale	7,622	8,082
Corporate notes and bonds | Fair Value Measurement on Recurring Basis | Significant Unobservable Inputs
Securities Available For Sale:
Total Securities Available For Sale	0	0
Pooled SBA
Securities Available For Sale:
Total Securities Available For Sale	25,101	25,174
Pooled SBA | Fair Value Measurement on Recurring Basis
Securities Available For Sale:
Total Securities Available For Sale	25,101	25,174
Pooled SBA | Fair Value Measurement on Recurring Basis | Quoted Prices in Active Markets for Identical Assets
Securities Available For Sale:
Total Securities Available For Sale	0	0
Pooled SBA | Fair Value Measurement on Recurring Basis | Significant Other Observable Inputs
Securities Available For Sale:
Total Securities Available For Sale	25,101	25,174
Pooled SBA | Fair Value Measurement on Recurring Basis | Significant Unobservable Inputs
Securities Available For Sale:
Total Securities Available For Sale	0	0
Other | Fair Value Measurement on Recurring Basis
Securities Available For Sale:
Total Securities Available For Sale	981	964
Other | Fair Value Measurement on Recurring Basis | Quoted Prices in Active Markets for Identical Assets
Securities Available For Sale:
Total Securities Available For Sale	981	964
Other | Fair Value Measurement on Recurring Basis | Significant Other Observable Inputs
Securities Available For Sale:
Total Securities Available For Sale	0	0
Other | Fair Value Measurement on Recurring Basis | Significant Unobservable Inputs
Securities Available For Sale:
Total Securities Available For Sale	0	0
Corporate equity securities | Fair Value Measurement on Recurring Basis
Trading Securities:
Total Trading Securities	3,699	7,946
Corporate equity securities | Fair Value Measurement on Recurring Basis | Quoted Prices in Active Markets for Identical Assets
Trading Securities:
Total Trading Securities	3,699	7,946
Corporate equity securities | Fair Value Measurement on Recurring Basis | Significant Other Observable Inputs
Trading Securities:
Total Trading Securities	0	0
Corporate equity securities | Fair Value Measurement on Recurring Basis | Significant Unobservable Inputs
Trading Securities:
Total Trading Securities	0	0
Mutual funds | Fair Value Measurement on Recurring Basis
Trading Securities:
Total Trading Securities	487	807
Mutual funds | Fair Value Measurement on Recurring Basis | Quoted Prices in Active Markets for Identical Assets
Trading Securities:
Total Trading Securities	487	807
Mutual funds | Fair Value Measurement on Recurring Basis | Significant Other Observable Inputs
Trading Securities:
Total Trading Securities	0	0
Mutual funds | Fair Value Measurement on Recurring Basis | Significant Unobservable Inputs
Trading Securities:
Total Trading Securities	0	0
Certificates of deposit | Fair Value Measurement on Recurring Basis
Trading Securities:
Total Trading Securities	614	350
Certificates of deposit | Fair Value Measurement on Recurring Basis | Quoted Prices in Active Markets for Identical Assets
Trading Securities:
Total Trading Securities	614	350
Certificates of deposit | Fair Value Measurement on Recurring Basis | Significant Other Observable Inputs
Trading Securities:
Total Trading Securities	0	0
Certificates of deposit | Fair Value Measurement on Recurring Basis | Significant Unobservable Inputs
Trading Securities:
Total Trading Securities	0	0
Corporate notes & bonds
Securities Available For Sale:
Total Securities Available For Sale	7,622	8,082
Corporate notes & bonds | Fair Value Measurement on Recurring Basis
Trading Securities:
Total Trading Securities	655	655
Corporate notes & bonds | Fair Value Measurement on Recurring Basis | Quoted Prices in Active Markets for Identical Assets
Trading Securities:
Total Trading Securities	655	655
Corporate notes & bonds | Fair Value Measurement on Recurring Basis | Significant Other Observable Inputs
Trading Securities:
Total Trading Securities	0	0
Corporate notes & bonds | Fair Value Measurement on Recurring Basis | Significant Unobservable Inputs
Trading Securities:
Total Trading Securities	$ 0	$ 0

Fair Value - Assets and Liabi_2

Fair Value - Assets and Liabilities Measured at Fair Value on Non-Recurring Basis (Details) - Fair Value, Measurements, Nonrecurring - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Commercial, industrial and agricultural
Impaired loans:
Assets, fair value disclosure	$ 5,627	$ 2,910
Commercial, industrial and agricultural | Quoted Prices in Active Markets for Identical Assets
Impaired loans:
Assets, fair value disclosure	0	0
Commercial, industrial and agricultural | Significant Other Observable Inputs
Impaired loans:
Assets, fair value disclosure	0	0
Commercial, industrial and agricultural | Significant Unobservable Inputs
Impaired loans:
Assets, fair value disclosure	5,627	2,910
Commercial mortgages
Impaired loans:
Assets, fair value disclosure	10,909	1,147
Commercial mortgages | Quoted Prices in Active Markets for Identical Assets
Impaired loans:
Assets, fair value disclosure	0	0
Commercial mortgages | Significant Other Observable Inputs
Impaired loans:
Assets, fair value disclosure	0	0
Commercial mortgages | Significant Unobservable Inputs
Impaired loans:
Assets, fair value disclosure	$ 10,909	$ 1,147

Fair Value - Additional Informa

Fair Value - Additional Information (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
Fair Value Disclosures [Abstract]
Impaired loans, recorded investment	$ 30,892	$ 20,755
Impaired loans allowance	$ 5,154	$ 2,301

Fair Value - Quantitative Infor

Fair Value - Quantitative Information about Level 3 Fair Value Measurements for Financial Instruments Measured at Fair Value on Non Recurring Basis (Details) - Fair Value, Measurements, Nonrecurring - Significant Unobservable Inputs $ in Thousands	Mar. 31, 2020USD ($)	Dec. 31, 2019USD ($)
Commercial, industrial and agricultural
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	$ 5,627	$ 2,910
Commercial mortgages
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Fair value	$ 10,909	$ 1,147
Measurement Input, Loss Severity | Commercial, industrial and agricultural | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0	0
Measurement Input, Loss Severity | Commercial, industrial and agricultural | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	1	0.6
Measurement Input, Loss Severity | Commercial, industrial and agricultural | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.22	0.54
Measurement Input, Loss Severity | Commercial mortgages
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.25
Measurement Input, Loss Severity | Commercial mortgages | Minimum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input		0.25
Measurement Input, Loss Severity | Commercial mortgages | Maximum
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	1	0.01
Measurement Input, Loss Severity | Commercial mortgages | Weighted Average
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Measurement input	0.30	0.52

Fair Value - Carrying Amount an

Fair Value - Carrying Amount and Fair Value of Financial Instruments (Details) - USD ($) $ in Thousands	Mar. 31, 2020	Dec. 31, 2019
ASSETS
Securities available for sale	$ 570,582	$ 542,313
Carrying Amount
ASSETS
Cash and cash equivalents	136,341	192,974
Securities available for sale	570,582	542,313
Trading securities	5,507	9,809
Loans held for sale	1,815	930
Net loans	2,828,745	2,784,562
FHLB and other restricted interests	27,975	27,868
Interest rate swaps	4,461	1,877
Accrued interest receivable	11,530	11,486
LIABILITIES
Deposits	(3,100,216)	(3,102,327)
FHLB and other borrowings	(225,722)	(227,907)
Subordinated debentures	(70,620)	(70,620)
Interest rate swaps	(5,362)	(2,362)
Accrued interest payable	(1,760)	(1,597)
Total Fair Value
ASSETS
Cash and cash equivalents	136,341	192,974
Securities available for sale	570,582	542,313
Trading securities	5,507	9,809
Loans held for sale	1,825	933
Net loans	2,789,605	2,765,133
Interest rate swaps	4,461	1,877
Accrued interest receivable	11,530	11,486
LIABILITIES
Deposits	(3,112,646)	(3,106,798)
FHLB and other borrowings	(233,544)	(230,679)
Subordinated debentures	(62,647)	(64,084)
Interest rate swaps	(5,362)	(2,632)
Accrued interest payable	(1,760)	(1,597)
Quoted Prices in Active Markets for Identical Assets | Total Fair Value
ASSETS
Cash and cash equivalents	136,341	192,974
Securities available for sale	981	964
Trading securities	5,455	9,758
Loans held for sale	0	0
Net loans	0	0
Interest rate swaps	0	0
Accrued interest receivable	6	6
LIABILITIES
Deposits	(2,675,399)	(2,674,511)
FHLB and other borrowings	0	0
Subordinated debentures	0	0
Interest rate swaps	0	0
Accrued interest payable	0	0
Significant Other Observable Inputs | Total Fair Value
ASSETS
Cash and cash equivalents	0	0
Securities available for sale	569,601	538,554
Trading securities	52	51
Loans held for sale	1,825	933
Net loans	0	0
Interest rate swaps	4,461	1,877
Accrued interest receivable	3,387	3,238
LIABILITIES
Deposits	(437,247)	(432,287)
FHLB and other borrowings	(233,544)	(230,679)
Subordinated debentures	(62,647)	(64,084)
Interest rate swaps	(5,362)	(2,632)
Accrued interest payable	(1,760)	(1,597)
Significant Unobservable Inputs | Total Fair Value
ASSETS
Cash and cash equivalents	0	0
Securities available for sale	0	2,795
Trading securities	0	0
Loans held for sale	0	0
Net loans	2,789,605	2,765,133
Interest rate swaps	0	0
Accrued interest receivable	8,137	8,242
LIABILITIES
Deposits	0	0
FHLB and other borrowings	0	0
Subordinated debentures	0	0
Interest rate swaps	0	0
Accrued interest payable	$ 0	$ 0

Revenue from Contracts with C_3

Revenue from Contracts with Customers - Schedule of Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2020	Mar. 31, 2019
Non-interest Income
Service charges on deposit accounts	$ 1,527	$ 1,481
Wealth and asset management fees	1,293	1,042
Mortgage banking	337	239
Card processing and interchange income	1,128	1,029
Net gains (losses) on sales of securities	0	148
Other income	1,079	2,214
Total non-interest income	$ 5,364	$ 6,153